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1. Introduction 
1.1. The place of liposomal systems in pharmaceutical  research  
Considerable efforts have been made  in pharmaceutical research to  develop new drug delivery 
systems  that  enhance  the  efficacy and  safety  of  existing  drugs  and  that  underlie  optimized  
drug  therapy.  Liposomes  find  perhaps  the  most  extensive  use  as  drug  carriers,  and  many  
previous  studies  have  demonstrated  the  enhanced  efficacy  of  encapsulated  drugs  and  the  
reduction of the  side-effects of drugs  so  entrapped  in this  manner1"4.  These vesicles  consisted  
of  phospholipid  bilayers  were  discovered  by  Bangham  et  al.  in  1964  when  rational  drug  
delivery  research  was  at  a  very  beginning  stage.  The  few  systems  then  under  investigation,  
now  fallen out  from  the  forefront of  the  research,  had  no  identified  targets  in  humans  (i.e.  
polyclonal  antibodies),  were too  limited  in their tasks  (i.e.  albumin microspheres)  whilst  other  
advanced  systems (i.e.  nylon microcapsules),  could not  degrade  in the body5.  In contrast,  the  
cell  like,  organized  structure  of  liposomes  together  with  their  unique  versatility  in terms  of  
composition,  physical  characteristics  and  function  in  vivo,  ensured  an  intellectually  
multifaceted  challenge  in  the  liposomology  to  apply  the  system  successfully.  Structural  
versatility  and  its  control  provided  the  inclusion  of  almost  any  type  of  drug  in  the  medical  
application  of  liposome-based  therapeutics  and  facilitation  of  related  technology.  It  also  
enabled  us  to  evade  physiological  ambushes  or  to  circumvent  anatomical  barriers.  Today,  
liposome  based  therapeutics  are  used  routinely  in  the  clinic  to  prolong  or  save  lives  and  
protect from disease, while others are  still being tested  in the clinic. Novel  ideas and concepts 
are fermenting in laboratories worldwide, potentially to lead to effective constructs6. 
1.2. Physicochemical  and structural  properties of lipid membranes and  liposomes  
Liposomes  are  simply vesicles  which  an  aqueous  volume  is  entirely  enclosed  by a  membrane  
composed  of  lipid  molecules  (usually  phospholipids).  They  form  spontaneously  when  these  
lipids are  dispersed  in aqueous media,  giving rise to  a population of vesicles which may range 
in  size  from tens of nanometers  to  tens  of  microns  in diameter.  Alternatively,  liposomes  can  
be  composed  of  entirely  artificial  components7'8,  chosen  for  their  improved  chemical  
properties.  Bilayer  membrane  vesicles  can also  be constructed  of  a wide range  of other  types  
of lipid: for example, fatty acids, double chain secondary amines, or cholesterol derivatives9.  
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Fig.  1.:  Some common  naturally-occuring phosphatidyl  phospholipids.  A: the most  frequent  
phosphoglycero-esters,  B: sphingomyelin  and ether-linked  phosphatidyl  choline (from Ref.  10)  
Two  sorts  of  phospholipids  exist:  phosphoglycerides  and  sphingolipids,  together  with  
their  corresponding  hydrolysis  products  (Figure  1A  and  B).  The  most  common  phospholipids  
are  phosphatidyl  cholines  (PC).  Molecules  of  PC  are  not  soluble  in  water  in  the  accepted  
sense,  and  in  aqueous  media  they  align  themselves  closely  in  planar  sheets  in  order  to  
minimize  the  unfavourable  interactions  between  the  bulk  aqueous  phase  and  the  long  
hydrocarbon  fatty  acid  chains.  Such  interactions  are  completely  eliminated  when  the  sheets  
themselves  to  form  sealed  vesicles.  Phosphatidyl  cholines  contrast  markedly  with  other  
amphipathic  molecules  (detergents,  lysolecithin)  in  that  bilayer  sheets  are  formed  in  
preference  to  micellar  structures.  This  is  thought  to  be  because  the  double  fatty  acid  chain  
gives  the  molecule  an  overall  tubular  shape,  more  suitable  for  aggregation  in  planar  sheets  
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compared  with  detergents  with  a  polar  head  and  single  chain,  whose  conical  shape  fits  nicely  
into  a spherical micellar  structure10.  
1.2.1. Phosphatidyl choline  membranes  
Phase  transitions.  At  different temperatures,  lecithin  membranes  can  exist  in different 
phases,  and  transitions  form  one  phase  to  another  can  be  detected  by  physical  techniques  as  
the  temperature  is  increased.  The  most  consistently  observed  of  these  phase  transitions  is  the  
occurring  at  the  highest  temperature,  in  which  the  membrane  passes  from  a  tightly  ordered  
'gel'  or  'solid'  phase,  to  a  liquid  -crystal  phase  at  raised  temperatures  where  the  freedom  of  
movement  of  individual  molecules  is  higher.  
The  most  widely  used  method  for  
determining  the  phase  transition  temperature  
(Tm)  is  microcalorimetry11"13.  In  general  
increasing  the  chain  length,  or  increasing  the  
saturation  of  the  chains  increases  the  
transition  temperature.  Membranes  made  
from  egg  yolk  lecithin  have  a  transition  
temperature  from -15  °C to - 7  °C,  compared  
from  mammalian  sources  which  are  usually  
in the range zero to 40  °C.  
An  understanding  of  phase  
transitions  and  fluidity  of  phospholipid  
membranes  is  important  both  in  the  
manufacture  and  exploitation  of  liposomes,  
since  the  phase  behavior  of  a  liposome  
membrane  determines  such  propreties  as  
permeability,  fusion,  aggregation,  and  
protein  binding,  all  of  markedly  affect  the  
stability  of  liposomes,  and  their  behavior  in  
biological  systems.  
In  bilayer  membranes,  the  molecules  
Me 
+ 
CH2—CH2 -
Me 
Plane  of  membrane  
CHAIN  2  
Fig. 2.:  Schematic conformation  of phosphatidyl 
choline  in biological  membranes (from Réf.  10.)  
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appear  to  be  aligned  with  the  glycerol  backbone  approximately  perpendicular  to  the  plane  of  
the  membrane,  and  the  phosphocholine  head  group  in  a  straight  line  roughly  parallel  with  the  
membrane  surface.  This  conformation  would  be  expected  to  reduce  the  distance  between  
positive  and  negative  charges  within  the  phospholipid  molecule.  Because  of  the  three  methyl  
groups  attached  to  the  quaternary  nitrogen,  the  head  group  of  phosphatidyl  choline  in  this  
conformation  is  very  bulky,  and  occupies  an  area  of  the  membrane  (42  A2)  greater  than  that  
taken  up  by  the  two  fatty  acids  in  their  
straight  chain  configuration  (~  39  A2).  In  
order  to  overcome  this,  the  hydrocarbon  
chains  are  thought  to  tilt  relative  to  the  
plane  of  the  membrane  at  an  angle  of  58°,  
in  such  a  way  as  to  fill  up  the  extra  space  
created  by the head groups,  and to  bring  the  
chains  of  adjacent  molecules  into  closer  
proximity,  to  maximze  Van  der  Waals  and  
other non-covalent  interactions  (Figure  2.).  
Phase  separation.  As  the  
temperature  increases,  the  fatty  acid  chains  
tend  to  adopt  conformations  other  than  the  
straight  all-trans  chain  configuration,  such  
as  the  gauche  conformation  state,  and  this  
tends  to  expand  the  area  occupied  by  the  
chains,  giving  rise  to  a  decrease  in  bilayer  
thickness  upon  transition  from  gel to  liquid-
crystalline  phase  (Figure  3.).  In  fact,  the  
transition  from  gel to  liquid  crystal  does  not  
->f 60° 
miuijiiiiMuiium 
gel phase  (Lp>)  
Fig.  3.:  Phase transitions  of  phospholipid 
membranes during the elevation  of temperature 
(from Ref.10.) 
occur  in  a  single  step  for  lecithin,  but  involves  two  transitions:  the  main  transition  already  
described,  and  the  pre  transition,  about  five  degrees  below  the  main  transition,  at  which  a  
change  in head  group  orientation  may  occur;  the  heat  of  this  transition  is  very  low  compared  
with  the  main  transition.  In the  temperature  range  between  the  two  transitions,  the  membrane  
adopts  a  ruffled appearance,  in which  it  is transformed  from  a planar  to  an  undulating  surface  
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with  a  fairly long,  regular periodicity.  The orientation  adopted  by the hydro-carbon  chains to 
the plane of the membrane is not certain. 
Binary  mixtures  of  synthetic  lecithins  of  different chain  lengths  give  a  main  transition  
intermediate  in  temperature  between  those  of  the  components,  unless  the  chain  lengths  are  
very  different, in which case two  separate transitions  are  observed;  in the temperature  region  
between the  transitions  solid  and fluid phases  may co-exist,  each enriched  in one or the  other  
of the components14"16. 
1.2.2. Lipids influencing the properties of  the biological membranes 
1.2.2.1. Other neutral phospholipids 
In  addition to  PC,  neutral  lipid  bilayers  may be  composed  of  sphingomyelin  (Figure  IB),  or  
alkyl  ether  lecithin  analogues.  Replacement  of  ester  groupings  by  ether  linkages  increases  
thev resistance of  such lipids to  hydrolysis,  while not  apparently  greatly affecting the physical  
properties  of  the  membranes.  The  presence  in  sphingomyelin  of  the  amide  linkage  and  
hydroxyl  groups,  in the  region  corresponding  to  the  glycerol backbone  of  lecithin,  gives rise 
to  hydrogen  bond  interactions  which may  explain the more  highly ordered  gel phase  relative  
to  phosphatidyl  choline. Natural mammalian  sphingomyelin  extracts  show phase transitions  in  
the region of 37 °C, in accord with the paucity of unsaturated  fatty acid chains found in these 
mixtures.  In  contrast,  natural  phosphatidyl  cholines  have  a  much  higher  content  of  
unsaturations,  and  give  phase  transitions  well  below  body  temperature.  Generally  
sphingomyelin  membranes  are  considered  more  stable  and  tightly  packed  than  lecithin  
bilayers,  as  shown  by  decreased  permeability  to  solutes,  greater  resistance  to  lysis  by  bile  
salts, and lower membrane fluidity. 
The  other  neutral phospholipid  found commonly  in natural membranes  is phosphatidyl 
ethanolamine  (PE)  (Figure  1A)17"18.  Possessing  an  unsubstituted  quaternary  ammonium  
group,  which  is protonated  at  neutral pH.  This  lipid  differs from PC  in two  respects:  first  in  
that  its head  group  is  smaller than the  bulky phosphocholine  of lecithin,  and  secondly,  that  it  
is able to  take part  in hydrogen  bonding  interactions  with its neighbours  in the membrane.  In  
consequence of the  small head groups it is not  necessary for the chains to  tilt  in the gel phase; 
molecules  are  are  oriented  perpendicular  to  the  plane  of the  membrane  below the  gel phase,  
and no pre-transition is observed.  Saturated PEs have have transition temperatures approx.  20 
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°C  higher  than  their  PC  analogues:  this  is  attributed  to  the  formation  of  intramolecular  
hydrogen  bonds  which  have  to  be  broken  before  PE  can  undergo  transition  to  the  more  
expanded  liquid-crystalline  phase.  At  low  pH  PEs  also  display  PC-like  transition  
temperatures, as the nitrogen becomes protonated,  and hydrogen bonding reduced. 
1.2.2.2. Negatively charged phospholipids 
In  negatively-charged  (acidic)  phospholipids  all  three  possible  forces  regulating  head  group  
interactions  of  bilayer  membranes  can  come  into  play  namely:  steric  hindrance,  hydrogen  
bonding  and  electrostatic  charge.  Thus  for  dipalmitoyl  phosphatidyl  glycerol  (DPPG),  the  
bulky  glycerol  group,  in  conjunction  with  electrostatic  repulsion  of  the  unprotonated  
phosphate  at  pH  7,  gives  it  a  main  transition  temperature  of  almost  10  °C  below  that  of  
dipalmitoyl  phosphatidyl  choline  (DPPC).  In  contrast,  DPPA  (dipalmitoyl  phosphatidic  acid)  
has a small head group  and! single proton at neutral pH which, like PE,  can undergo  hydrogen  
bonding, resulting  in an elevated main transition temperature for pure DPPA bilayers. At high 
and low pH, the Tm is brought down, particularly at high pH, where electrostatic repulsion can 
push the head groups apart. 
1.2.2.3.  Cholesterol 
Cholesterol  (Choi)  does  not  by  itself  form bilayer  structures,  but  it  can  be  incorporated  into  
phospholipid  membranes  in very high concentrations,  even 2  :1 molar  ratios  of cholesterol to 
PC. In natural membranes, the molar ratio varies from 0.1-1.0, depending upon the anatomical  
and  cellular  location.  Being  an amphipathic molecule  Choi inserts into  the membrane  with its  
hydroxyl  group  oriented  towards the  aqueous  surface, and the  aliphatic  chain  aligned  parallel  
to  the  acyl  chains  in  the  center  of  the  bilayer.  The  presence  of  the  rigid  steroid  nucleus  
alongside  the  first  ten or  so  carbons of the  phospholipid  chain has the  effect of reducing  the  
freedom of motion of these carbons, while at the same time creating space for a wide range of 
movement  for the  remaining  carbons towards the  terminal  end  of the  chain.  Above  a  certain  
concentration  of  Choi, the membrane area occupied  by the  acyl chains and sterol combined  is  
greater  than  or  equal  to  that  taken  up  by  the  phosphocholine  head  group,  so  that  PC  
membranes  with  high  levels  of  Choi  do  not  show  the  chain  tilt  that  is  observed  in  the  gel  
phase of liposomes composed of pure PC. Addition of Choi to PC membranes has a marginal 
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effect on the position of the Tm: in DPPC the Tm  changes from 41 °C to 44 °C with 33 mol % 
Choi.  With  increasing  concentration,  however,  cholesterol  is  able to  eliminate  evidence  of  a  
phase transition altogether, reducing the enthalpy of phase change to  zero at  50 mol %, and in 
so  doing  altering  the  fluidity  of  the  membrane  both  below  and  above  the  phase  transition  
temperature19.. 
1.2.2.4. Non-structural components 
For  structural  purposes,  no  components  other  than  phospholipids  and  sterols  need  to  be  
incorporated  into  the  membrane.  Because  the  membrane  interior  is  a  very  fluid  aliphatic  
medium composed  of molecules  associated  by non-covalent  interactions  it  will readily  accept  
and  retain  a  wide  range  of  lipophilic  compounds  without  the  need  for  any  fixed  chemical  
structural  specificity.  Under  normal  circumstances  these  compounds  can  probably  be  
accommodated  in the  membrane  to  a  concentration  of  about  1-10 %  by  weight  without  the  
serious  disruption20  of  the  basic  bilayer  structure,  although  the  membrane  integrity  as  
determined  by  fluidity  or  permeability  may  well  be  altered.  In  particular  cases,  where  a  
specific  interaction  is  known  to  occur  between  the  compound  and  other  membrane  
components (i.e. fatty acids, a-tocopherol), concentrations higher than  10 % may be achieved. 
Conversely,  relatively  low  concentrations  of  certain  substances,  such  as  some  polyene  
antibiotics, will completely disrupt the membrane, as a result of specific interactions. 
1.3. Technology of liposomes: from preparation to application 
1.3.1. Methods of preparation 
The  preparation process  of  liposomes  for  medical  /  pharmaceutical  purposes  mostly  consists  
of  three  main  stages.  During  the  first,  hydration  step  phospholipid  molecules  associate  into  
lipid  bilayer  membranes  which  form  liposomes  finally.  Both  the  hydration  and  the  sizing  
stages  are  recommended  to  carry  out  above  the  gel-liquid  crystal  phase  transition  
<y | 
temperature  . Several of the preparation approaches listed in Figure 4. have been scaled up to 
industrial  scale.  If possible,  the  use  of  a  high-shear  homogenizer  for the production  of  small  
vesicles  is  a  first  choice. No  organic  solvents  are  required  to  dissolve the  lipids first,  nor  are  
detergents  necessary  to  hydrate  the  lipids,  and  there  is  easy  access  to  the  appropriate  
8 
(commercially  available)  equipment.  Problems  with  
this method  may  arise  if more  than  one  lipid  bilayer  
component  is  present.  Further  upscalable  
technologies: 
•  the  detergent  removal  method,  where  the  
detergent  is  removed  from  the  mixed  micelles  
containing  lipid bilayer  components22"24.  
•  the  ethanol  injection  method25,  where  the  
lipids  are  dissolved  in  ethanol  and  then  mixed  with  
the aqueous phase; and finally, 
•  the  bilayer  forming  lipids  can  be  lyophilized  
in  the  presence  of  the  (lipophilic)  drug.  Upon  
hydration  stage  the  highly  porous  lipid  cake  forms  
liposomes  (MLV  >  1 pm)  and  the  lipophilic  drug  is  
liposome  associated26.  Liposomes  are  classified  in  
the  Table  1.  based  on  their  structural  parameters  
(size,  lamellarity)  which  is  in  close  connection  with  
the method  of preparation. 
1.3.2. Loading  of drugs into  liposomes  
Selection  of  an  encapsulation  protocol  is  largely  
dictated  by  concerns  such  as  encapsulation  
efficiency, drug  to  lipid  ratio,  drug  retention,  ease  of  
preparation,  compatibility  with  regulatory  agencies,  
sterility,  ease  of  scale  up,  cost  efficiency,  as  well  as  
liposome and drug  stability27'28.  
Passive  entrapment  techniques  rely  on  the  
ability  of  liposomes  to  capture  a  certain  aqueous  
volume  (including  dissolved  solutes)  during  vesicle  
formation.  Trapping  efficiencies  vary  dramatically,  
ranging  1% or  less for SUVs to as high as 88% for 
Hydration  of the lipid  components  
I Mechanical  method  
•  Vortexing  or hand shaking of phospholipid 
dispersions (MLV) 
•  Microfluidizer technique (mainly  SUV) 
•  High-shear  homogenization  (mainly  SUV)  
II Methods  based on replacement  of  organic 
solvent(s)  by aqueous  media 
•  Removal  of organic solvents before 
hydration (Bangham's  method; MLV,  OLV,  
SUV) 
•  Reverse phase evaporation  (LUV, OLV, 
MLV) 
•  Use of water immiscible  solvents:  ether  
infusion (solvent vaporization)  (MLV,  OLV,  
LUV) 
•  Use of water miscible solvents:  ethanol  
injection (MLV, OLV,  SUV)  
III Methods  based on detergent  removal  
•  Gel  exclusion chromatography (SUV) 
.  Dialysis (LUV, OLV, MLV) 
•  Fast dilution  (LUV, OLV) 
IV Methods  based on size transformation and 
fusion 
•  Spontaneous fusion of SUV in the gel 
phase  (LUV)  
•  Freeze-thawing  (MLV)  
•  Freeze-drying  (MLV)  
j _ 
Sizing stage 
•  High pressure  extrusion 
•  Low pressure  extrusion 
•  Ultrasonic treatment 
1 
Removal  of  non-encapsulated  
material 
•  Dialysis  
•  Ultracentrifugation  
•  Gel-permeation  chromatography  
•  Ion-exchange  resins  
Figure 4.:  Methods  for the preparation  of  
pharmaceutical  liposomes (from Ref. 21.) 
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Based on structural  parameters  Based on method  of liposome  preparation  
•  MLV, multilamellar  large vesicles-  >0.5pm  •  REV, single or oligolamellar vesicles made by 
the reverse-phase evaporation  method  
•  OLV, oligolamellar  vesicles-  0.1-1pm 
•  SUV, small  unilamellar  vesicles- 20-100  nm •  MLV-REV,  multilamellar vesicles made  by the 
reverse-phase evaporation  method  
•  MUV,  medium sized unilamellar  vesicles  •  SPLV, stable plurilamellar  vesicles  
•  LUV, large unilamellar vesicles-  >100 nm •  FATMLV, frozen and thawed MLV 
•  GUV,  giant  unilamellar vesicles-  >1pm  •  VET, vesicles prepared by extrusion  methods  
• M W ,  multivesicular  vesicles (usually  large  
>1pm) 
•  DRV, dehydration-rehydration  vesicles  
29 
Table  1.:  Liposome classification on the basis of  pharmaceutical  aspects ( Ref. 21.)some M L V s  .  
Although  maximum  trapping  efficiencies  are  obviously  desirable,  this  property  is  often  
limited  by  the  type  of  vesicles  (SUV,  LUV  or  MLV)  required  for  in  vivo  applications.  The  
low  trapping  efficiencies  of  SUV  systems  largely  stem  from  their  low  trapped  volume  (0.2-
0.8  pi  /  pmol  lipid).  LUVs  and  MLVs  can  exhibit  higher  values  (1-30  pi  /  pmol  lipid)  and  
also  can  be  prepared  at  higher  lipid  concentrations,  leading  to  improved  trapping  efficiencies.  
Significant  differences  in  trapping  efficiencies  are  also  experienced  within  each  vesicle  type  
depending  on  lipid  concentration  limitations  and  aqueous  trapped  volumes  inherent  in  the  
specific liposome preparation  procedures.  
Active  trapping  techniques.  At  these  procedures  drug  /  lipid  ratios  are  far greater  than  
predicted  on  the  basis  of  theoretical  aqueous  trapped  volumes.  At  the  one  group  of  agents  
which  are  insoluble  in  water  and  can  be  incorporated  into  the  lipid  bilayer  during  vesicle  
formation.  These  materials  are  generally  treated  as  lipids  themselves,  being  mixed  
homogenously  with  the  lipid  component  prior  to  vesicle  hydration  step.  The  second  group  of  
the  agents  are  water-soluble  materials  which  interact  with  the  polar  head  group  of  
phospholipids  and are sequestered  by the  liposomes30'31.  
The  most  important  approach  to  the  active  trapping  is  the  pH  gradient  or  remote  
loading  method  which  was  developed  for  the  high  performance  entrapment  of  amphiphilic  
weak  bases  (such  as  doxorubicin  and  adriamycin)32"37.  The  entrapment  efficiency  can  be  
increased  up  to  100  %  in  liposomes  by  using  an  ammonium  sulfate  gradient.  This  loading  
strategy,  in  principle,  allow  empty  liposomes38  to  be  loaded  with  a  drug  'at  the  patients  
bedside'.  This is an interesting  option  if a labile drug or  labile liposomes need to  be used. 
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Assay Methodology  / analytical  target  
Characterization 
PH 
Osmolarity 
Phospholipid  concentration  
Phospholipid  composition  
Cholesterol  concentration  
Drug  concentration  
pH meter 
Osmometer 
Lipid phosphorous content /  HPLC  
TLC and  HPLC  
Cholesterol  oxidase assay and HPLC 
Appropriate  method  
Chemical  stability  
PH 
Phospholipid  peroxidation  
Phospholipid  hydrolysis  
Cholesterol  autooxidation  
Antioxidant  degradation  
pH meter 
Conjugated dienes,  lipid peroxides and FA 
composition  (GLC)  
HPLC, TLC,  and FA concentration 
HPLC,  TLC 
HPLC,  TLC 
Physical  stability  
Vesicle size distribution:  submicron  range  
micron  range  
Electrical  surface potential  and surface pH 
Numbers of  bilayers  
Percentage of entrapped  drug  
Dilution dependent  drug  release  
Relevant  body fluid induced  leakage  
DLS 
Coulter  Counter,  light  microscopy,  laser  
diffraction and GEC 
Zeta-potential  measurements  
SAXS,  NMR  
GPC,  IEC, and protamine  precipitation  
Retention  loss on dilution 
GPC,  IEC and protamine  precipitation  
Biological  characterization  
Sterility 
Pyrogenicity 
Animal  toxicity  
Aerobic and anaerobic  cultures  
Rabbit  or  LAL test 
Monitor survival,  histology and  pathology  
Table 2.:  Quality control assays of liposomal formulations; DLS, dynamic light scattering;  FA, fatty acid;  GPC, 
gel permeation  chromatography;  LAL, Limulus Amoebocyte Lysate; NMR, nuclear  magnetic resonance;  SAXS,  
small  angle X-ray scattering; TLC, thin  layer chromatography.  Based  on Ref. 39. 
1.3.3.  Sterilization,  s torage  and  quality  control  
Issues  that  are  related  to  the  parenteral  administration  of  l iposomes  are  the  produc t  sterility  
and  the  absence  o f  pyrogens.  The  preferred  way  of  sterilizing  l iposomes  is  by  autoclaving.  
This  is  a  realistic  option;  if  the  p H  condit ions  are  optimal,  the  drug  is  heat  stable  and  
lipophilic.  Otherwise,  reliance  on  filtration  th rough  membranes  with  0.2  p m  pores  and  /  or  
aseptic  product ion  is  necessary3 9 .  
During  the  s torage  o f  l iposomal  formulat ions  oxidation  can  be  prevented  by  excluding  
oxygen  from  the  injection  vial,  by  addition  o f  an  anti-oxidant  (i.e.  vitamin  E)  or  by  selection  
of  saturated  acyl-chains  in  the  phospholipid4 0 .  If  those  condit ions  cannot  met,  freeze  drying  
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may be  considered.  Liposomes  can be  successfully freeze dried  if the proper  lyoprotectant  is  
used  and proper  freeze-drying  conditions  are  chosen41.  They  prevent  aggregation  and fusion 
upon reconstituting  the  cake.  It  is not  always possible to  avoid drug  leakage  from  liposomes  
after freeze-drying-rehydration cycle,  but  recent  insights  into the  mechanism of  lyoprotection  
improve the chances for success33. 
The methods of quality control for liposomal formulations are  summarized  in Table 2.  
Regarding to the quality there are  several special investigating procedures  (i.e. drug release42)  
compared to other dosage forms. 
1.4. Liposomes for medical  applications 
1.4.1. Reasons of using liposomes for pharmaceutical purposes 
1. Direction.  Liposomes  in one hand  can target a drug to the intended  site of action in 
the body, thus  enhancing  its therapeutic  efficacy (drug targeting,  site  specific delivery),  in the 
other  hand  they  may  also  direct  a  drug  away  from  those  body  sites  that  are  particularly  
sensitive to the toxic action of it (site  avoidance-delivery).  
2.  Duration.  Liposomes  can  act  as  a  depot  from  which  the  entrapped  compound  is  
slowly  released  over  a  time.  Such  a  sustained  release  process  can  be  exploited  to  human  
therapeutic  (but  nontoxic)  drug  levels  in  the  bloodstream  or  at  local  administration  site  for  
prolonged  periods  of  time.  Thus,  an  increased  duration of action  and  decreased  frequency  of  
administration are beneficial consequences. 
3.  Protection.  Drugs  incorporated  in  liposomes,  in  particular  those  entrapped  in  the  
aqueous  interior,  are  protected  against  the  action  of  detrimental  factors  (i.e.  degradative  
enzymes)  present  in  the  host.  Conversely,  the  patient  can  be  protected  against  detrimental  
toxic effects of drugs (Duration). 
4.  Internalization.  Liposomes  can  interact  with  target  cells  in  various  ways  and  
therefore  able to  promote  the  intracellular  delivery  of drug  molecules  that  in their  free  (non-
encapsulated)  form  would  not  be  able  to  enter  the  cellular  interior  due  to  unfavorable  
physicochemical characteristics (i.e. DNA molecules). 
5.  Amplification.  If  the  drug  is  an  antigen,  liposomes  can  act  as  immunological  
adjuvant in vaccine formulations43,44. 
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These  objectives  for  using  liposomes  are  not  mutually  exclusive;  often  successful  
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applications of liposomes are based on a combination of two  or even more  .  
1.4.2 Classification of liposomes based on their composition  and  in vivo  application  
The  liposome  system  has  a  major  advantage  over  competing  other  colloidal  drug  carrier  
systems:  it  allows  almost  infinite  possibilities  to  alter  structural  and  physicochemical  
characteristics  in  order  to  tailor  liposome  formulations  to  specific  therapeutic  needs.  The  
simplest  way  to  classify  the  plenty  of  possible  liposome  versions,  four  major  liposome  types  
can be broadly distinguished  on the basis of composition  and  in vivo  application  (Figure  5.).  
Conventional  liposomes.  These  can  be  defined  as  liposomes  that  are  typically  
composed  of  only  phospholipids  (neutral  and  /  or  negatively  charged)  and  /  or  cholesterol.  
They  can  vary  widely  in  their  physicochemical  properties  such  as  size,  lipid  composition,  
surface  charge  and  fluidity  of  the  phospholipid  bilayers.  Conventional  liposomes  are  
characterized  by  a  relatively  short  blood  circulation  time.  When  administered  in  vivo  by  a  
variety  of  parenteral  routes  (often  by  intravenous  administration),  they  show  a  strong  
tendency  to  accumulate  rapidly  in  the  phagocytic  cells  of  the  mononuclear  phagocyte  system  
(MPS),  also  often  referred  as  reticuloendothelial  system  (RES).  The  major  organs  of  
accumulation  are  the  liver  and  spleen,  both  in  terms  of  total  uptake  and  uptake  per  gram  of  
tissue.  An  abundance  of  MPS  macrophages  and  a  rich  blood  supply  are  the  primary  reasons  
for the preponderance  of particles  in the  liver  
and  the  spleen.  A  logical  therapeutic  
translation  of  this  MPS-directed  distribution  
behavior  is  that  conventional  liposomes  may  
be  attractive  for  drug  delivery  to  MPS  
macrophages.  Indeed,  the  literature  contains  
many  examples  of  successful  applications  of  
conventional  liposomes  for  the  delivery  of  
antimicrobial  agents  to  infected  
macrophages45.  Another  interesting  
application  of macrophage  targeting  involves  
the  delivery  of  immunomodulators  to  
conventional 
cationic stealth 
targeted 
Figure 5.:  The  four major  liposome types  applyed  
for medical  purposes.  From  Ref. 21. 
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increase  the  capacity  of  macrophages  to  kill  neoplastic  cells46,47  and  to  increase  resistance  
against  infectious  microorganisms48.  Liposome-based  vaccines  have  proved  effective  in  
experimental  models  against  viral,  bacterial  and  parasitic  infections49"52,  as  well  as  tumors53.  
Several  liposomal  vaccines  have  been  tested  in  humans,  and  one  of  these,  a  liposomal  
hepatitis-A vaccine, has received marketing approval in Switzerland54.  
Long-circulating  (or  'stealth')  liposomes.  In  spite  of  the  above-mentioned  valuable  
applications  for  conventional  liposomes,  the  fast  and  efficient  elimination  of  conventional  
liposomes  from  the  circulation  by  liver  and  spleen  macrophages  has  seriously  compromised  
their  application for the treatment  of the wide range of diseases involving other tissues. Long-
circulating  liposomes  opened  a  realm  of new therapeutic  opportunities  that  were  up to  then  
unrealistic  because  of  efficient MPS  uptake  of  conventional  liposomes21.  Perhaps  the  most  
important  key  feature  of  long  circulating  is  that  they  are  able  to  extravasate  at  body  sites  
where  the  permeability  of  the  vascular  wall  is  increased.  Fortunately,  regions  of  increased  
capillary  permeability  include  pathological  areas  such  as  solid  tumors  and  sites  of  infection  
and  inflammation. It  is  illustrative  for the  importance  of the  long-circulation  concept  that  the  
only two  liposomal anticancer products that  are approved for human use are based on the use 
of  long-circulating  liposomes  for  the  tumor  selective  delivery of  antitumor  drugs  (Doxil®  or  
Caelyx®  and  DaunoXome®).  At  present  the  most  popular  way  to  produce  long-circulating  
liposomes  is to  attach hydrophilic  polymer  polyethylene  glycol  (PEG)  covalently to  the  outer  
surface55'59.  Steric  stabilization results from the  local surface concentration of highly hydrated 
PEG  groups  that  create  a  steric  barrier  against  interaction  with  molecular  and  cellular  
components  in  the  biological  environment60,61.  The  ability  of  these  type  of  liposomes  to  
persist  in  the  blood  and  to  localize  in  sites  of  pathology  also  provides  applications  for  drug  
delivery  outside  the  oncology.  Other  examples  can  be  found  in  recent  evaluations  of  their  
usefulness  for  delivery  of  scintigraphic  agents62,63,  antibiotics64,  and  cytokines65,66.  Their  
persistence  in  blood  suggests  that  they  may  also  prove  effective to  provide  slow  release  of  
therapeutics  such  as  biomacromolecules  into  the  systemic  circulation67.  One  study  of  this  
approach has been reported using the peptide hormone vasopressin68.  
Targeted  liposomes.  These  vesicles  have  specific 'homing  device'  on  their  surface to 
enhance target  site binding69.  Till this time among them the immunoliposomes  attached  with  
antibodies  or  antibody  fragments  were  investigated  the  most  extensively70"73.  Aldough  
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immunoliposome  systems  have  been  examined  for  various  therapeutic  applications,  the  
primary focus has been the targeted  delivery of  anticancer  agents74.  Successful attempts  have  
been  made  to  prolong  the  half-life of  immunoliposomes  after  intravenous  administration  by  
coating  with  PEG,  thus  giving  them  a  greater  chance  to  reach  target  sites  other  than  MPS  
macrophages.  Not  only  antibodies  can  be  attached  to  liposomes  as  homing  devices  to  the  
surface of liposomes in order to  obtain a targeted  drug release  system but  also hyaluronic acid 
derivatives and folic acid are capable to  direct  liposomes to  different tumor cells. One of these 
cell types (mostly  in lung cancers) over-expresses the  CD44 cell surface receptor  which binds 
hyaluronic  acid  whilst  at  the  other  type  of  these  cells  folate  receptors  are  presented  in  
enormously high number75"77. 
Cationic  liposomes.  These  are  the  youngest  members  of  the  liposomal  systems  and  
they  are  in  spotlight  among  the  delivery  systems  under  development  for  improving  the  
delivery of  genetic  material78*80.  Their  cationic  lipid  components  interact  with,  and  neutralize,  
the  negatively  charged  DNA,  thereby  condensing  the  DNA  into  a  more  compact  structure.  
The resulting  lipid-DNA complexes,  rather than DNA encapsulated  within liposomes,  provide  
protection and promote cellular internalization and expression of the condensed plasmid81"84.  
1.5. Importance of the interactions between liposomes and  polymers  
Many attempts have been made to avoid the MPS-trapping of liposomes and to  achieve longer 
half-lives  in  the  bloodstream  by  modification  of  the  liposomal  surface.  As  we  mentioned  
previously  successful  results  have  been  obtained  by  the  modification  of  liposomes  with  
poly(ethylene  glycol)  (PEG)  derivatives. In addition to  this approach until recently  only a few 
studies  have  dealt  with  other  polymers  physically  adsorbed  on  the  surface  of  liposomes  
(Figure  6.).  It  can  be  explained  by  two  major  reasons  why  we  need  for  such  researches.  
Primarily;  however  PEG  protects  liposomes  from  MPS  it  may  also  inhibit  their  interaction  
with  the  biological  milieu  at  the  site  of  action.  For  example:  if  we  covered  liposomes  with  
biodegradable  polymers  adsorbed  physically  it  might  be  easier  to  transport  active  agents  into  
cells  in pathological  tissues.  Secondly,  this  is  a more  simple  and  cheap  way to  prepare  steric  
stabilized vesicles compared to the production of peggylated phospholipids.  
Poly  (vinyl  alcohol)  (PVA)  and  PVA  modified with  a  hydrophobic  moiety  (PVA-R),  
were examined as  a  coating  material  for  liposomes  to be loaded with  an  anticancer  drug,  
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B, 
Figure 6.:  Section A,:  liposome membrane with peggylated  phosphatidyl  ethanolamine  lipid  component;  
section  B,:  liposome surface with  polymers attached  by physical  forces ie.  hydrogen  bonds.  
doxorubicin  by  Takeuchi  et  al.85'86.  Besides  the  animal  experiments  (pharmacokinetic  and  
distribution  studies)  they  performed  dynamic  laser  light  scattering  (DLS)  measurements  and  
determined  the  coating  amounts  of  polymers.  It  was  shown  that  PVA-R  binds  to  liposomes  
with higher  affinity than PVA due to  the anchoring  of the 'R'  alkyl  chains.  
The  kinetic  (long-term)  stability  of  dimyristoyl  phosphatidyl  choline  (DMPC)  
liposomes  was  examined  by  Grohmann  et  al.  who  incorporated  PVA  and  poly(vinyl  
pyrrolidone)(PVP)  derivatives  into  the  bilayer  membrane  of  the  vesicles87.  These  experiments  
were  carried  out  at  different pH  values,  and  the  enhancement  of  the  average  vesicle  diameter  
was  checked  by  DLS  after  certain  time  intervals  for  3  months.  It  was  concluded  that  the  rate  
of  diameter  increase  can  be  significantly  diminished  by  stabilizing  the  dispersions  with  PVP  
or  PVA  and  its  co-vinyl  acetal,  propional  or  butyral  copolymers.  In  another  approach  
differential scanning  calorimetry  was  used  to  examine  the  polymer-liposome  interactions88.  It  
is  also  very  noteworthy  the  work  of  de  Rubalcava  et  al.89  who  made  a detailed  examination  
on the  interactions  between liposomes and  hydoxypropylmethylcellulose.  
-CH-NH-C-0-(Et-0}-
Steric  stabilization  
with  covalently  
grafted  polymers  
(PEG-derivatives) 
Steric  stabilization  
with  physically  
adsorbed  polymers  
16 
Enteral  absorption  of  insulin  was  examined  from  liposomes  coated  with  a  
mucoadhesive polymer:  chitosan  (CS). In  this  study the  change  in the zeta potential afforded 
evidence  of the polymer  layer on the  liposome  surface86  and the  ability of mucoadhesion  was  
compared  with other  polymers  (PVA and poly(acrylic  acid))  attached to  cholesterol  and  'R'.  
In the  case  of  insulin  loaded  liposomes coated  with CS,  added  orally, the rate  of  diminishing  
of  the  blood  glucose  level  was  almost  the  same  as  it  was  experienced  when  insulin  was  
administered itself, subcutaneously. 
In  another  interesting  study  published  by  A.  de  la  Maza  et  al.90  protection  of  PC  
liposomes  against  the  solubilizing  effect  of  a  nonionic  surfactant,  Triton  X-100  was  
investigated  after  a  bacterial  glycoprotein  (GP)  exopolymer  had  been  adsorbed  onto  the  
surface. They concluded  that  the higher the proportion  of the GP in the  system the  lower  the  
surfactant ability to  saturate and solubilize liposomes.  The fact that surfactant concentration at  
sublytic  and  lytic  level was lower  and  similar than the  surfactant critical micelle  concentration  
indicates  that  the  interaction  at  these  two  levels  was  mainly ruled  by the  action of surfactant 
monomers and by the formation of complex mixed micelles: surfactant/PC/GP. 
Polymerized  surfactant  vesicles  entrapping  colloidal  platinum  were prepared  by J.  H.  
Fendler et  al. for catalytic and artificial photosynthetic purposes. They built in double bonded 
functional  groups  either  to  the  head  group  or  the  hydrocarbon  chain  of  the  surfactant  
molecules of which the vesicular  systems were prepared.  The polymer network was produced 
by photopolymerization (UV light)91. 
Poly[N-(2-hydroxypropyl)methacrylamide]  (polyHPMA)92  which  is  a  popular  
biomedical polymer and xanthan gum93 were also used for steric stabilization of liposomes. 
1.6. Research  aims  
In the knowledge of the preliminaries discussed before (1.5.)  my aim was to develop methods 
for  the  detailed  investigation  of  the  liposome-polymer  interactions  in  model  systems  
composed  of  three  liposome  types:  1.  soy  lecithin  phospholipid  (SLPL)  /  Choi  /  dicetyl  
phosphate  (DCP) = 25  : 3  : 2, 2. DPPC / Choi / DCP = 4  : 1 :  1, 3. DPPC / Choi = 2  :  1, and 
neutral polymers:  PVA,  PVP,  dextrane.  The  methods  of  examinations  are  summarized  in the 
Figure 7. 
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Direct  methods:  
1.  Quantitative  measurement  of  the  amount  of  polymers  adsorbed  on  the  surface  of  
liposomes with different analytic methods, 
2.  Dynamic  laser  light  scattering  measurements  in  order  to  prove  the  existence  of  
polymer-adsorption on the basis of increasing vesicle diameters, 
3.  Titration microcalorimetry  for the detection of the heat  effects caused  by the interaction 
of polymers and the liposome surface, 
4.  X-ray  diffraction  examinations  to  investigate  the  structural  changes  of  the  lipid  
membrane brought by the polymer-adsorption 
5.  High  precision  densimetric  measurements  to  examine  the  expansion  /  compression  of  
the  liposome  membrane  on  the  basis  of  molar  excess  volume  (Vme)  values  calculated  
from the densimetric data. 
I  also  used  an  indirect,  test  dye  release  method  which  detects  the  changes  in the  membrane  
permeability caused by the polymer adsorption. This process consisted of two main stages: 
1.  Optimization  of  the  active  entrapment  (remote  loading)  of  a  weakly  basic  test  dye,  
acridine orange into the liposomes 
2.  Test dye release with self-developed membrane diffusion cells. 
On the basis of the results  obtained I  tried to  explain the reasons of the differences in the rate 
of adsorption  observed considering the physical and chemical properties of the liposome types 
and polymers. 
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2. Experimental 
2.1. Materials 
Soy  lecithin  (SL):  Lucas Mayer,  Germany.  Dipalmitoyl phosphatidyl  choline  (DPPC),  dicetyl  
phosphate  (DCP)  cholesterol  (Choi)  and  N-[2-Hydroxyethyl]  piperazine  -N'-[2-
ethanesulfonic  acid]  (Hepes):  Sigma,  St.  Louis,  Mo.,  USA.  Poly  (vinyl  pyrrolidone)  K30  
(PVP) Mr  «  40000,  acridine orange hydrochloride  (AO),  Tris-(hydroxymethyl)-aminomethane  
(Tris),  and  hexadecylpyridinium  chloride  (HDPC1):  Fluka  Chemie,  Switzerland.  Protamine  
hydrochloride  (Prot):  F.  Hofimann-La  Roche,  Switzerland.  Sephadex  G50f  xerogel:  
Pharmacia,  Sweden.  Poly  (vinyl alcohol) PVA Mr  «  72000,  dextrane  (DEX) Mr  «  40000  and  
Triton X-100: Reanal, Budapest,  Hungary.  All other  substances like,  sodium chloride,  sodium  
hydroxide,  disodium  hydrogenphosphate,  potassium  dihydrogenphosphate,  potassium  iodide,  
iodine,  ammonium  sulphate,  ethanol,  methanol,  chloroform  are  the  products  of  Reanal  and  
have the purity of analytical grade. 
2.2. Methods 
2.2.1. Analytics of phospholipids 
There  were  two  important  reasons  to  use  phospholipid  analytics  during  my  works:  in  one  
hand  it  had been important to know the amount  of phospholipids in the SL before I started to 
prepare  liposomes  made  of that,  in the  other  hand  it  had to  be  known the  loss  of  liposomes  
caused  by  gel  permeation  in  case  I  separated  the  liposome  entrapped  AO  from  the  non-
entrapped  one.  It  is  also  advised  to  measure  the  liposome  concentration  before  the  gel  
permeation  because  at  downsizing  with  the  LiposoFast®  (Avestin  Inc.  ON,  Canada)  the  
membrane  filter  may  bound  a  certain  amount  of  liposome.  Accordingly  I  determined  the  
amount  of  liposomes  as  phospholipid  concentration  with  the  Rouser's  assay94'95.  In  this  
method,  phospholipid  phosphorus  is  first  acid-hydrolysed  to  inorganic  phosphate  with  
perchloric acid 70 % at 200 °C. This is converted to phospho-molybdic  acid  by the addition of 
ammonium  molybdate,  and  the  phospho-molybdic  acid  is  quantitatively  reduced  to  a  blue  
coloured  compound  by ascorbic  acid  at  100  °C.  The  intensity of the  blue colour  is measured 
by spectrophotometer  (UVIKON 930,  A. = 810 nm). 
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Fig.  7.:  Survey  figure  of  the  methods  used.  After  preparation  of  the  liposomal  systems  there  are  two  main  
approaches  to investigate the polymer-liposome interactions:  1. direct examinations with analytic and structure-
scanning methods (LEFT),  2.  indirect  examination  on the basis of the change  in the AO permeability  (RIGHT).  
2.2.2.  Preparation  of  liposomes  
Determination  of  the  phospholipid  (PL)  content  of  SL  was  made  according  to  the  PL-assay  
described  previously.  This  value  was  found  to  be  85  ±  1.2  %.  The  SL  was  the  major  
component  of  the  one  liposome  type  of  which  lipid  composition  was  set  to  soy  lecithin  
phospholipid  (SLPL)  /  Choi  /  DCP  =  25  :  3  :  2  (mol  /  mol).  The  other  two  systems  had  the  
composition  of  DPPC  /  Choi  /  DCP  =  4  :  1  :  1 and  DPPC  /  Choi  = 2 : 1 .  Liposomes  were  
prepared  by  the  classic  lipid  film  hydration  (or  Bangham)  method96'97.  The  lipids  were  
dissolved  in  a  mixture  of  9:1  (v/v)  chloroform  /  methanol.  Lipid  films  were  prepared  on  the  
wall of a round-bottomed  flask  with  a Rotadest  2118 vacuum  evaporator.  
After the  removal  of  all traces  of organic  solvent  films were  hydrated  at  50  °C either  in  
0.01  M  phosphate  buffered  saline  (PBS)  or  in Hepes  buffered saline  (HBS)  both  with  the  pH  
value  of  7.4.  0.1  M  or  0.06  M  ammonium  sulphate  (pH  =  5.0)  was  used  as  hydration  medium  
if I  wanted  to  prepare  AO  loaded  liposomes  afterwards.  Lipid  films  of  liposomes  intended  for  
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the  surface charge  density  measurements  were hydrated  in phosphate  buffer (PB)  which  was  
free of sodium chloride and had the concentration of 0.01 M. 
The  average  vesicle  diameter  of  the  coarse  multilamellar  vesicle  (MLV)  dispersions  
formed  by  powerful  hand  shaking  of  the  round  bottomed  flasks  was  reduced  either  by  
sonication with a Realsonic RS-16F ultrasonic bath or  extrusion through a  100 nm pore  sized 
polycarbonate filter  (device: LiposoFast™)  depending on the composition of liposomes.  Both  
the  hydration  and  downsizing  processes  has  to  be  done  above  the  main  phase  transition  
temperature  (Tm)  of  the  phospholipids  used98'100.  The  size  of  liposomes  was  checked  by  
dynamic  laser  light  scattering  (DLS)  measurements  finally.  The  survey  of  the  experiments  
made on the freshly prepared liposomes is depicted in the Figure 7. 
2.2.3. DLS measurements  
DLS  measurements  were done  in order to  follow the  change of the liposome diameter  during  
the different work  stages.  I  used  a  SEMA-Tech  SEM-633 with He-Ne laser,  5 mW (k  =  633  
nm)  instrument  at  a  measuring  angle  of  90  0  for  100  seconds.  The  samples to  be  examined  
were  diluted  approx.  50-fold with the  suitable media.  The other  important  role of DLS exams  
was to prove the existence of polymer-adsorption on the basis of increasing vesicle  diameters.  
In these  cases  samples with the polymer  /  liposome ratios  of 0.04-0.80  (w/w) were  examined  
immediately after their dilution. 
2.2.4. Determination of surface charge density 
The surface charge density of liposomes dispersed  in 0.01 M phosphate buffer (pH = 7.4) was 
determined with a Miitek PCD 02 particle charge detector  (PCD). The liposome concentration  
was  diluted  to  7.5  mg /  ml  in each  original  dispersion,  then these  systems  were  titrated  with  
0.1 M HDPC1 solution in the measuring cell (10 ml) of the PCD. The streaming potential was 
measured  simultaneously  and the endpoint  of this process was indicated  by a PCD  signal of 0 
mV. Based on the consumed volume of HDPC1 the surface charge density is calculated by: 
Z  =  V°charge  *  CHDP+  /  HI  ( 1 )  
where: Z = surface charge density in milliequivalents per gram (mEq / g), 
V°Charge = consumed volume of 0.1 M HDPC1 (ml) at zero charge, 
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m = mass of the  liposomes  in the measuring  cell  (g),  
C H D P +  = concentration ofHDPCl (0.1  M).  
2.2.5. Determination  of the amounts of polymer  adsorbed  
I  added  PVA  or  PVP  or  DEX  at  the  polymer  /  liposome  ratios  of  0.04-0.80  (w/w)  to  the  
liposomes  prepared  in PBS  and  after  mixing  by  vortexing  the  systems  they  were  incubated  at  
25  ±  0.1  °C.  In  the  samples  got  into  adsorption  equilibrium,  liposomes  with  adsorbed  
polymers  on  their  surface  were  separated  either  by  ultracentriftigation  with  a  Beckmann  TL  
100  ultracentrifuge  or  after  aggregating  with  protamine  by  centrifugado n  from  the  dispersion  
media97'101.  The  equilibrium  concentrations  (Ce)  of  the  non-adsorbed  polymers  were  
determined  form the supernatants  by the following analytic methods (Figure  8.).  
A,  Analysis  of  the  total  organic  carbon  (TOC)  content  with  Euroglas  TOC-1200  Total  
Organic  Carbon  Analyzer.  This  method  is  suitable  for  the  quantitative  determination  of  
all  the  polymers  (PVA,  PVP,  DEX)  we  used.  The  concentration-TOC  signal  (ppm)  
calibration  lines  were  recorded  between  the  concentration  range  of  25-800  pg  /  ml  for  
each  polymer.  
B,  Spectrophotometric  measurement  (UV-VIS)  with  Kontron  Uvikon  930  
spectrophotometer  for the  determination  of PVA  and PVP.  In  the  case  of PVA  I  added  
specific  reagent  solution  
containing  iodine,  boric  
acid  and  potassium  
iodide102  to  the  samples  
taken  from  the  
supernatants.  The  reagent  
forms  a  green  coloured  
complex  from  PVA  and  
the  optical  density  of  this  
colour  is  measurable  at  
X =  670  nm.  The  
concentration-absorbance 
calibration  line  was  
PROTAMINE 
> -
DISPERSION TO 
BE  EXAMINED 
CENTRIFUGATION 
2000 g  , 5  min.  
EASILY  SEPARATABLE  
AGGREGATED  DISPERSION  
ULTRACENTRIFUGATION 
100000 g ,45  min.  
ANALYTICS  OF  POLYMERS:  
•  Measurement  of  the  total organic  carbon  (TOC):  PVA,  PVP,  DEX  
•  Spectrophotometric  (UV-VIS):  PVA  (green complex,  X  = 670  nm),  
PVP  (in  UV)  
•  Liquid  scintillation  (LSC)  measurement  of  3H  labelled  DEX  
Fig.  8.:  Quantitative  analysis  of the polymers adsorbed.  Liposomes  
are  separated  from  their  dispersion  media  by  centrifugation  first,  
then  polymers are determined  from the  supernatants.  
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recorded  between  the  
concentration  range  of  
6.25-40  pg  /  ml.  The  
measurement  of  PVP  is  
more  complicated:  in  the  
absence  of  a  specific  
chromophore  -  producing  
reagent  I  was  forced  to  
measure  in  the  UV.  In  
order  to  circumvent  this  
problem  we  minimized  the  
disturbing  effect  of  
unbound  liposomes  and  Prot.  I  added  increasing  amounts  of  Prot  to  dispersions  
containing  only  liposomes  and  after  centrifuging  them  I  searched  for  the  absorbance  
minimum  at  210  nm.  Figure  9.  reveals  the  optimal  ratio  of Prot  /  phospholipid  at  where  
PVP  displays  an  absorbance  maximum  in  ethanol  : water  = 9 : 1  (v/v).  I  added  Prot  in  
this  Prot  /  phospholipid  ratio  to  the  liposome-PVP  systems  to  be  examined.  This  was  
followed  by  centrifugation,  dilution  of  an  aliquot  of  the  supernatant  with  96  %  ethanol  
and measurement  of the concentration of unadsorbed  (equilibrium) PVP at 210  nm.  
C,  Measurement  of the  radioactivity  with  liquid  scintillation  (LSC)  for the  determination  of  
DEX.  There  was  certain  amount  of  DEX  labelled  with  tritium  by the  isotope  exchange  
reaction103  in  a  device  built  specially  for  this  purpose104.  The  non-labelled  (cold)  DEX  
and  the  tritiated  DEX  (3HDEX)  were  added  to  the  liposome  dispersions  at  the  rate  of  
DEX  /  3HDEX  = 9 : 1  in order  to  obtain  samples  with  different DEX  /  liposome  (w/w)  
ratios.  After  ultracentrifiigation  of  the  samples  10  pi  of  the  supernatants  were  shaken  
with  5  ml  of  toluene-Triton-X  scintillation  cocktail  then  the  radioactivities  were  
determined  with  a  Searle  Delta  300  liquid  scintillation  counter.  The  5th,  liposome-free  
member  of  the  SLPL  /  Choi  /  DCP  system  was  chosen  as  standard  with  the  DEX  
concentration  of 0.181  % (w/v)  and the activity of 353278  cpm.  
The  adsorption  was  expressed  via  the  adsorption  isotherms  at  25  ±  1  °C  by  the  following  
equation: 
Ratio  of  Prot/phospholipid  (w/w)  
Fig. 9.: Determination  of the optimal Prot/phospholipid  ratio as the 
minimum  of absorbance  in order  to minimize the disturbing effect 
of nonprecipitated  liposomes  and  Prot  in the measurement  of non-
adsorbed  PVP.  
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nSpo,ymer  =  V  • (Co  -  Ce)  /  100  • m  (2)  
where:  nSpoiymer = the amount  of polymer  adsorbed  on  1 g of liposome  (mg /  g)  
Co = the  initial concentration of the polymer  (mg /100  ml)  
Ce  = the measured  equilibrium concentration  (mg /100  ml)  
V  = the volume of the  sample  (ml)  
m = the mass of liposomes  in the  sample  (g).  
Examinations  are  classified by Table  3. regarded to  the type of liposomes  and  polymers.  
Type  of  liposomes  Polymer Method  of  analysis  after  UCF  
Method  of  analysis  
after  PROT  
SLPL  /  Choi  /  DCP  =  
25  : 3  : 2 
PVA VIS VIS 
PVP - u v 
DEX LSC -
DPPC / C h o i /  DCP  =  
4 : 1 : 1 
PVA VIS,  TOC  -
PVP TOC -
DEX TOC,  LSC  -
DPPC/Choi  =  
2  : 1 
PVA VIS,  TOC  -
PVP TOC -
DEX TOC,  LSC  -
Table  3.:  Classification  of the  analytic  methods  used  for  determination  of  the  amount  of  polymers  adsorbed.  
UCF  and  PROT  mean  the  way  of  separation  of  liposomes  either  by ultracentrifiigation  or  centrifugation  after  
protamine-aggregation. 
2.2.6.  Densimetry  and molar excess  volumes  
The  molar  excess  volumes  (VmE)  of  the  systems  can  be  calculated  on  the  basis  of  the  density  
and compositional  data  in cm3  /  mol:  
VmE  =  [(x,  •  M,  + x2  • M2)  /  p1>2 ]  -  [x,  • M,  / p j  -  [x2  • M2  /  p2]  (3)  
where:  M(i  =  1,2)  are  the  average  molar  weights  of liposomes  and polymers,  x(i =  1,2)  are  the  
molar  fraction,  pi  and  p2 are the  densities  (g  /  cmJ)  of the  liposome  dispersions  in the  absence  
of polymers  and  polymer  solutions  with  Co concentration.  pi 2 is the measurable  density  of  the  
polymer  /  liposome = 0.04-0.50  (w/w)  systems.  
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Measurements  were  made  with  an  Anton  Paar  DMA  58  densimeter.  Densimetry  is  
based  on  high  precision  frequency  measurement  and  the  density  of  the  complex  liquid  
examined is calculated from the change of frequency105. 
2.2.7. Calorimetric measurements 
These  exams  were  made  on  the  SLPL  /  Choi  /  DCP  liposomes  and  PVA.  The  data  were  
obtained  with  a  thermometric  thermal  activity  monitor  (TAM  Type  2277)  titration  
microcalorimeter.  A  portion  of  the  original  liposome  dispersion  (0.333  cm3  in  HBS)  was  
diluted to 2.00 cm3 with HBS, and the total enthalpies (Table 2) were determined when 800 pi 
of 0.5 % PVA were added  in ten steps. The PVA /  liposome ratio  (w/w) was set from 0.04 to 
0.4.  The  total  duration  of this  measurement  was  17 hours  (2  hours  for the  baseline  and  1.5  
hours for each step). I  also measured the dilution enthalpies of both liposomes and PVA under 
the same conditions as mentioned above.  
2.2.8. XRD studies 
The  aim  of  XRD  measurements  was  to  detect  the  structural  changes  brought  about  by  
polymer  adsorption  in the  liposome  membrane.  The  samples  containing  SLPL /  Choi  /  DCP  
liposomes  in HBS  and PVA or PVP were first  dried  in a heat  box and then exposed  to  water  
vapour  at  60  °C  for  12  hours.  They  were  measured  in  both  dry  and  water-vapour-exposed  
conditions over  angles from  1° to  8° (Philips PW1820 dififractometer Cu Ka,  40 kV,  35 mA). 
The accuracy of identity period  (di,) was ± 0.01 nm. 
2.2.9. Small angle X-ray scattering (SAXS experiments)  
These  exams were used to justify the transition of the DPPC-liposomes from the gel to  liquid  
crystalline  phase.  Liposomes  were  composed  of  DPPC  (100  %)  or  DPPC  :  Choi  =  2  :1.  
Samples  were  heated  from  25  °C to  50  °C  in  eight  steps  while  small  angle  X-ray  scattering  
was measured  using a Kratky camera (KCEC/3 Anton-Paar,  Austria) with a position  sensitive  
detector  (PSD  50M,  Hecus  M.  Braun-Graz  X-Ray  Systems  GmbH,  Austria).  The  X-ray  
radiation was generated  by a Philips PW  1830 generator, and filtered trough a 20-micron thick 
Ni plate to  obtain a CuKa  radiation  (A, = 0.1542 nm). The width of the beam was  14 mm and 
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its thickness,  c.a.  80 mm at  the  sample.  The  camera was evacuated  to  about  10-2 torr  vacuum.  
The  samples  were  filled  into  a  1 mm  diameter  quartz  capillary  cell.  Data  were  collected  for  
1000 seconds  in the angle range of 2 0  = 0.1-7.9  degrees.  
2.2.10. Entrapment  of acridine orange  into  liposomes; membrane  diffusion experiments 
2.2.10.1.  Preliminary experiments  for the optimisation  of the  loading  procedure  
drug  modeling  test  dye  can  be  
explained  by  several  reasons.  
First  of  all  it  can  easily  be  
detected  spectrophotometrically  
because  of  its  high  molar  
extinction  coefficient.  The  weak  
basic  property  (pKa  =  9.25)  and  
the hydrophobic  character  of  
the  base  form  are  important  
factors  which  promote  the  
loading  of  AO  to  the  internal  
space  of  liposomes.  Several  
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2 5  ° C  (gel  phase)  
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Removal  of  non-entrapped  
AO  (gel  permeation)  
Fig.  10.: Mechanism  of the remote loading process. The  uncharged  
form of the weak  base passes through  the membrane  and  its  
sulphate salt  forms in the intraliposomal  space.  
antineoplastic  agents  having  similar  chemical  structure  can  be  transported  through  lipid  
membranes  by this  so called remote  loading  method.  
During  the  loading  optimisation  experiments  we  examined  the  effect of  AO  /  PL  ratio  
and  the  quality  of  the  buffer  in  the  extraliposomal  area  on  the  entrapment  efficiency.  Since  
liposomes  may  undesirablely  aggregate  during  loading34  it  is  also  necessary  to  check  the  
average  vesicle  size  by  DLS  simultaneously.  I  searched  for  the  optimal  AO  /  PL  ratio  and  
buffer  quality  by  which  the  highest  entrapment  efficiency with  the  smallest  aggregation  rate  
can be  resulted.  
The  pH of the  SLPL  /  Choi  /  DCP  liposome  dispersion  hydrated  in 0.06  M  ammonium  
sulphate  was  set  from  5.0  to  7.4  with  0.1  M  sodium  hydroxyde  and  after  it  had  been  divided  
into  three  equal  volumes,  three  buffer  solutions  with  pH  7.4  (Hepes-sodium  hydroxide,  Tris-
hydrochloric  acid,  and  phosphate  buffer)  were  added  so  that  the  intra-  and  extraliposomal  
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spaces  remain  isoosmotic.  This  fact  was  
achieved  by  addition  of  sodium  chloride.  
The  [PL]  was  cca.  0.027  M  and  the  
concentration  of  the  appropriate  buffer  was  
0.01  M  in  each  dispersions  at  the  end  of  this  
step.  AO was added to the  2 ml of aliquots  of  
these  dispersions  so  that  the  molar  ratio  of  
AO  /  PL  change  between  0.02-0.30  and  
[AO]  (Ci)  be  in the  range  of  0.30-4.50  mM.  
Due  to  the  pH-gradient  (ApH  «  2.4)  set  up  
between  the  intra-  and  extraliposomal  areas  
and  the  incubation  of  the  samples  at  50  °C  
for  1 hour  AO  can  be  concentrated  into  the  
intraliposomal aqueous phase  (Fig.  10.).  
The  entrapment  efficiency (Eopt  %)  of  
AO  was  determined  with  a  similar  manner  as  
it  was  described  before,  at  the  quantitative  
measurement  of  the  polymer  adsorption.  200  
Sephadex 
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Remove eluate & 
add sample 
if 
1 in  r  
Non-entrapped 
drug 
SPIN 
Liposomes free of 
external drug 
Fig.  11.:  Removal  of the non-entrapped  material  by  
minicolumn-centrifugation.  The  method  is  
satisfactory  for  solutes  less  than  7000  molecular  
weight 
pi of volumes  were  taken  from  the  samples  and  equal volume  of Prot  solution was  mixed  with  
them  so  that  we  set  the  Prot  /  PL  (w/w  ratio)  to  approx.  0.3.  The  aggregated  liposomes  were  
centriiuged  at  2000  g  for  5  minutes  and  the  concentration  of  the  non-entrapped  AO  (C2)  was  
measured  from  the  supernatants  spectrophotometrically  at  492  nm.  Based  on  these  
measurements: 
Eopt  %  = (I-C2/C1)  • 100.  (4).  
2.2.10.2.  Gel permeation  chromatography  
I  used  gel  permeation  chromatography  combined  with  centrifugation  in  order  to  separate  the  
non-entrapped  AO  from  the  loaded  liposomes.  According  to  Ref.  106.  the  Sephadex  G  50  
(fine)  xerogel  was  hydrated  in  FIBS  at  room  temperature  for  24  hours.  The  hydrated  gel  was  
filled  into  plastic  syringe  barrels  (3  ml)  which  were  placed  into  centrifuge tubes  with  suitable  
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size.  The  syringe  barrels  were  plugged  with  Marcherey-Nagel  (type:  MV)  filter  pads  with  the  
pore  size of  3 pm. The processing  of this method  is depicted  in the Figure  11.  
2.2.10.3.  Measurement  of AO release  from  liposomes  
According  to  the  optimisation  of  the  AO  loading  process - the  maximum  loading  effect  with  
the  minimum aggregation  rate-  we  added  Tris-HCl  buffer (pFl =  7.4,  0.1  M)  to  the  dispersions  
in  order  to  provide  the  permanence  of  pH  gradient  between  the  intra-  and  extraliposomal  
spaces during  loading.  In the  case  of  SLPL /  Choi / DCP  liposomes the AO / PL,  at the  DPPC  
/  Choi  systems  the  AO  /  total  lipid  (DPPC  +  Choi)  molar  ratio  was  set  to  0.1.  The  
extraliposomal  pH  of  the  2  ml  of  liposome  dispersions  hydrated  with  0.1  M  ammonium  
sulphate  solution  was  set  from  5.0  to  7.4  by  the  addition  of  0.1  ml  of  sodium  hydroxide  
solution  (0.047  M).  The  osmotic  equivalence  of  the  inner-  and  outer  liposomal  spaces  was  
reached  by  adding  calculated  amount  of  sodium  chloride  to  the  Tris-HCl  buffer  solution.  
Samples  with  the  final  volume  of  3  ml  were  incubated  for  1 hour  at  50  °C  and  then  cooled  to  
room  temperature  in  icy  bath  suddenly.  The  non-entrapped  AO  was  removed  by  gel  
permeation  combined  with  
centrifugation  from  the  
extraliposomal  media  (Figure  
11.).  While  the  loss  of  liposomes  
caused  by  gel permeation  can  not  
be  predicted  I  determined  the  
amount  of  liposomes  as  PL  
concentration  in  the  eluted  
dispersion  with  the  Ro user's 
assay. 
PVA  or  DEX  had  been  
added  to  the  samples with  known  
PL  content  in  the  polymer  /  
liposome  ratio  of 0.1,  0.3  and  0.8  
(w/w)  before  0.3  ml  of  them  
were  put  into  the  donor  phase  of  
Sampling port 
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(0.3 ml) 
Acceptor phase 
(3.0 ml)  -
Stirring magnet  —• 
Plastic 
corks 
-=-Modifyed 
-  HPLCvial  
-  (3 ml) 
^  Thermostated  
~¡  inner-and  outer  
-  water baths 
LIPOSOME  DISPERSION  
A-Rubber O-ring 
Dialyzing membrane 
Teflone ring 
Cap screw 
Fig.  12.:  Self-developed membrane diffusion cell  for the 
tests of  liposomal  acridine orange  release.  
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the  membrane  diffusion cell  (Figure  12.)  thermostated  to  37  °C.  0.5  ml of samples  for the  test  
dye  release  experiments  were  taken  from  the  receptor  phase  at  the  following  sampling  times:  
2,  4,  8,  12  and  24  hours  and  their  absorbance  was  measured  spectrophotometrically  (X  = 492 
nm).  The volume of each  sample was replaced  with PBS to the receptor  phase.  
For  the  calculation  of AO  released  from  liposomes  till  certain  sampling  times  I  need  to  
know  the  amount  of  AO  in  the  donor  phase  at  the  zero  time  point.  This  value  can  be  
calculated  from  the  result  of  the  concentration  measurement  (Cy)  made  after the  disruption  of  
eluted  liposomes  with  Triton-X  100  107.  This  result  gives  the  entrapment  efficiency (E  %)  of  
AO according to the Eq.  5.:  
E% = (CY  • [PL]x / C x  • [PL]y)  • 100  (5)  
where:  Cx  is  the  measured-in  concentration  at  the  beginning  of  loading  and  Cy  is  the  
entrapment  concentration  of  AO.  [PL]x and  [PL]y  are  the  phospholipid  concentrations  before  
and after the gel permeation  chromatography.  
If  E  %  is substituted  for the Eq.  6.  the  No amount  of AO  in the  donor  phase  (V2 =  0.3  
ml) is  obtained: 
N0 = N x  •  E% /100  • V2  / Vi  • [PL]Y  /  [PL]X  (6)  
where Nx  (mol)  is the  amount  of  drug  in the Vi  volume  (ml)  applicated  to  the  gel  column.  No  
is the base value for the calculation of the drug release results  as follows: 
Ni  =  Ci  • Vc  (t,)  
N2  = C2 • Vc  + Vs  •  Ci  (t2)  
N3 =  C3 • Vc  + Vs  •  (Ci  + C2)  (t3)  
Nn  =  Cn • Vc  + V s .  (C,  +  C2+...+C„-i)  (tn)  (7)  
where  Ci.n  values  are  the  drug  concentrations  (M)  of  the  samples  taken  from  the  acceptor  
phase  and  Nj.n  are  the  total  amounts  of  drugs  released  from  the  liposomes  till  predicted  
sampling  time  points  (ti-tn).  Vc  and  Vs  are  the  volumes  of  the  whole  diffusion  cell  (V°  =  
0.0033  1) and  samples  (Vs  =  0.0005  1). The  rate  of  the  cumulative  drug  release  (Rel%  as  the  
percentage  of N0)  at  the nth  sampling  is:  
Rel  %  = Nn /  No  • 100.  (8).  
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3.  Results  and  Discussion  
3.1.  Preparation  of liposomes  and  downsizing  
The  final  average  diameters  of  liposomes  used  for  different  examinations  are  summarized  in  
the  Table  4.  Downsizing  was  made  in order to  uniform the  size of  the  liposomes.  On the  basis  
of  DLS  data  we  have  concluded  that  downsizing  is easier  at  physiologic  pH  value  (7.4)  with  
both  ultrasonic  bath  and  extrusion  in the  case  of  all the  three  liposome  type  than  in the  0.1  M  
ammonium  sulphate.  While  the  size  of  SLPL  /  Choi  /  DCP  liposomes  could  only  be  
diminished  by  sonication,  at  the  other  two  liposome  types  containing  DPPC  as  major  
component  the  membrane-extrusion  method  was  employed  which  is  more  effective  than  
sonication  considered  to  the  favouring  of  downsizing  effect  and  monodispersity.  This  method  
resulted  average  size  of  approx.  110  nm  for  the  DPPC  /  Choi  /  DCP  and  DPPC  /  Choi  
liposomes.  We suppose  that  the  reason  of the more  troubled  downsizing  at  pH  =  5.0  is due  to  
weakly  acidic  functional  groups  on  the  polar  end  of  phospholipids  of  which  has  decreasing  
dissociation  ability  as  the  pH  of  the  dispersion  media  grows  more  acidic.  This  phenomena  
makes  the  surfaces of both  the  lipid  films to  be  hydrated  and  the  liposomes  more  hydrophobic  
therefore  it  is  more  difficult  to  hydrate  the  films  and  to  downsize  the  coarse  liposome  
Type  of  liposome  Method  of  downsizing 
pH =  7.4  
0.01  M  
PB 
pH =  7.4  
0.01  M  
PBS 
pH =  5.0  
0.1  M  
(NH4)2S04 
SLPL  / C h o i /  
DCP  =  
25  : 3  : 2 
Bath  sonication  
148.7 ±  13.8  nm 
(±sd) 
«40  mM  
150.3 ±  14.2  
nm  (±sd)  
«40  mM  
164.3 ±  13.4  
nm  (±sd)  
« 4 0  mM  
D P P C / C h o i / 
DCP  =  4 : 1 : 1  Extrusion 
110.4 ±5 .3 
nm  (±sd)  
20.26  mM  
111.7 ±  5.4  
nm  (±sd)  
20.26  mM  
1642±152 
nm  (±sd)  
60  mM  
DPPC/Choi  =  
2  : 1 Extrusion 
114.5 ±6.2 
nm  (±sd)  
16.16  mM  
116.2 ±7 .3 
nm  (±sd)  
16.16  mM  
151.2 ±  8.1  
nm  (±sd)  
60  mM  
Table 4.:  Average sizes of the liposomes  used  for different experiments.  Measurements  were done with  DLS  
and  data written  by italic letters show the  PL concentrations  of the  dispersions.  
dispersion  formed  because  liposomes  with  higher  surface  hydrophobicity  have  tendency  to  
fuse  or  aggregate  in  aqueous  media.  The  effectiveness  of  downsizing  is  influenced  in  one  
hand  by the  saturation  grade  of  the  fatty  acid  chains  of phospholipids  which  has  effect on  the  
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fluidity  of  the  liposome  membrane,  and  in  the  other  hand  by  the  lipid  concentration  of  the  
dispersions.  This  latter  fact  was  set  to  higher  values  (40  and  60  mM)  in  the  dispersions  
prepared  at  pH  =  5.0  because  the  dilution  resulted  by  the  entrapment  and  separation  of  AO  
would  make  the  final AO  diffusion examinations  impossible.  Probably  the  combined  effect  of  
the  saturated  lipids  composing  the  lipid  membrane,  the  presence  of DCP  in  16.7  %  (mol/mol)  
which  gives  a  weakly  acidic  characteristic  to  the  membrane  and  the  relatively  high  PL  
concentration  (60  mM)  might  cause  the  fact  that  downsizing  of  the  DPPC  /  Choi  /  DCP  
liposomes  in  ammonium  sulphate  was  not  successful  either  we  used  extrusion  or  bath  
sonication.  The  average  liposome  diameter  in  this  easily  sedimenting  dispersion  was  approx.  
1642 nm.  
3.2.  Results  of the surface charge  density  measurements  
At  the  streaming  potential  of  0  
mV  which  indicates  the  
neutralisation  of  the  liposomal  
surface,  the  V0charge  values  were  
calculated  from  the  equations  of  
the  regression  lines  fitted  to  the  
titration  curves  depicted  in  
Figure  13.  If  these  data  are  
substituted  for  Eq.  1.  the  Z  
surface  charge  density  values  are  
given.  In  the  case  of  DPPC  /  
Choi  /  DCP  liposomes  the  
regression  line  was  fitted  to  the  
last  two  data  points.  Regarding  to  the  Z  values  it  is  ascertainable  that  the  surface  of  DPPC  /  
Choi  liposomes  is  neutral  (Z  =  0.013  mEq  /  g)  because  of  the  equal  amount  of  positive  and  
negative  charges  on  the  head  group  of  the  phosphatidyl  choline  molecules.  The  Z  value  of  
0.136  mEq  /  g  is  given  by  negative  charge  represented  by  the  known  amount  of  DCP  (16.7  
mol/mol  %)  at  the  DPPC  /  Choi  /  DCP  liposomes.  The  surface  charge  density  of  the  SLPL  /  
Choi  /  DCP  system  is  more  than  three  times  higher  (Z  =  0.42  mEq  /  g)  compared  to  the  
0.1 MHDPC1  (PI)  
Fig.  13.:  Results  of  the  streaming  potentiometric  titration  of  
DPPC  /  Choi  = 2 : 1  - • - ,  DPPC  /  Choi  /  DCP  = 4 : 1 : 1  - • - ,  
and  SLPL /  Choi  / DCP  =  25  : 3  : 2  —A— liposomes with  HDPC1.  
The  surface charge  density  of 0.42  mEq  /  g  of the  SLPL  /  Choi  /  
DCP  liposomes  derives  from  the  negatively  charged  lipids  
occurred with high  amount  in  SL.  
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previous  one.  This  relatively  big  negative  charge  based  on  the  composition  derives  partly  
from the DCP (6.7 mol/mol %) and partly from the components of  SL like phospholipids  (85  
w/w %),  glycohpids,  sterols, tocopherols,  and carbohydrates108  which wear negative charge in 
unknown  rate.  Dispersions  have  titrated  with  HDPC1 became  aggregated  systems  after  the  
negative charge of liposomes had been neutralized. 
3.3. Quantitative description of the  polymer-adsorption  
The  Co-Ce value of polymer-concentration  change in the dispersions should be known in order 
to  calculate  the  amount  of  polymer  adsorbed.  Determination  of  the  Ce  equilibrium  
concentrations  was  carried  out  with  the  methods  described  in  the  experimental  section.  
According  to  the  Table  3. where two  methods were  used to  measure the  polymer-adsorption  
in  a  certain  polymer  /  liposome  =  0.04-0.80  (w/w)  system there  adsorption  isotherms  were  
recorded  on  the  basis  of  the  averages  calculated  from  the  results  of  the  two  different  
measurements.  Where  we  worked  only  with  one  method  there  the  averages  calculated  from  
three  parallel  measurements  (n=3)  were  used  for the  same  purpose.  Two  major  conclusions  
can  be  obtained  from  the  results  shown  in  Figures  14a-c  and  15.:  in  one  hand  the  rate  of  
adsorption for all the polymers is increasing in the row of DPPC /  Choi < DPPC / Choi / DCP 
<  SLPL /  Choi /  DCP liposomes,  in the other  hand apart  from small deviations the amount  of  
polymers  adsorbed  is decreasing  considered  to  the row of PVA>DEX>PVP.  In the following 
part  we  try to  explain these  experiences  regarding  to  the  composition  of the  liposome  types  
and the physical-chemical properties of the polymers. 
A,  The role of the phospholipid fatty acid-saturation 
As  the  temperature  increases  biological  membranes  get  to  the  liquid  crystalline  phase  
(La-) from the gel phase  (Lp-) through a transitional  state  (Pp>). In the La- phase the membrane 
is more fluid and has looser  construction than  in the  Lp- phase therefore if the membrane  is in 
the  La- phase  the  functional groups  on  the  membrane  are  able  to  get  interacted  with  other  
molecules  easier.  At  different  membranes  composed  of  chemically  homogenous  
phospholipids  the  Pp-L0>  transition  is  well  characterised  with  the  main  phase  transition  
temperature (Tm). The Tm depends on the quality of the PL head group, the chain length of the 
PL fatty acid  and the  saturation of these mostly.  While at the membranes containing DPPC as  
main  component  the  Tm  is  approx.  41  °C  1S,  at  the  bilayer-systems  built  up  from  SL  
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phospholipids  which  are  rich  in  
unsaturated  fatty acids,  this  value  
is  much  lower  (Figure  3.).  An  
exact  Tm  value  can  not  be  given  
here  because  of  the  chemical  
heterogeneity.  Apart  from  this  it  
is  known  that  the  Tm  values  of  
unsaturated  phospholipids  with  
different  head  groups  are  in  the  
range o f - 3 0  to +30  °C.  
The  measurements  of  the  
polymer-adsorption  were  made  
at  25  ±  1°C at which  temperature  
DPPC  liposomes  (Figures  14b  
and  c)  are  in  the  orderly  gel  
phase  and  have  more  rigid  
construction  than  SLPL  
liposomes.  These  latter  systems  
are  in  the  fluid,  liquid  crystalline  
phase  and  due  to  the  loose  
membrane  structure  are  more  
susceptible  to  form  secondary  
binding  forces  (i.e.  hydrogen  
bridges).  This  may  partly  explain  
that  SLPL  liposomes  have  high  
polymer  adsorbing  ability  
reaching  100  mg  /  g  facing  the  
smaller  values of 35-75  mg  /  g  of  
the DPPC  liposomes.  
^-"e  p o l y m e r  ( g / 1 0 0  m l )  
C e  polymer (g/100  ml)  
v - ' e  p o l y m e r  (g/100  ml)  
Figures  14a-c: Adsorption  isotherms  of PVA  —•—, PVP  —x—, and 
dextrane  — A — on  liposomes with different membrane 
compositions. 
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CeDEX(g/100  ml)  
Fig.  15.:  Results  of dextrane adsorption  based  on the liquid  scintillation  measurements  
B,  The role  of cholesterol content,  SAXS  experiments,  temperature  dependency  
In  addition  to  the  PL-quality  the  liposome-membrane  fluidity  is  influenced  by  other  
membrane  composing  lipids.  Among  them  cholesterol  has  outstanding  importance  because  it  
decreases  the  fluidity  and  increases  the  integrity  of  the  biological  membranes  through  filling  
the  "extra  spaces"  between  the  PL  molecules109.  The  increasing  of  the  membrane  composing  
molecule-integrity  involved  by  the  higher  cholesterol  content  inhibits  the  permeation  of  the  
polymer  -segments  into  the  membrane  by  which  the  amount  of the  polymer  adsorbed  may  be  
further  decreased.  
The  comparison  of  the  pure  DPPC  and  DPPC  /  Choi  liposomes  can  be  seen  in  the  
Figures  16a  and  b  obtained  by  SAXS.  Intensities  of  the  peaks  recorded  in the  h  (nm"1)  range  
of  1.50-2.50  represent  the  rate  of  orderliness  of  the  lipid  membrane.  At  the  pure  DPPC  
liposomes  these  peaks  disappeared  in  the  temperature  range  of  pre-transition  and  transition  
(a).  This  phenomena  is not  particular  to  the  DPPC  /  Choi  liposomes  (b)  and  may be  explained  
by  the  literatural  experiences:  the  presence  of  Choi  decreases  or  eliminates  (from  50  mol/mol  
%)  the  differential  calorimetric  (DSC)  heat  effect  of  the  gel  to  liquid  crystalline  phase  
transition19. 
According  to  my  conception  the  diminishing  of  the  polymer  adsorbing-ability  is  
explainable  with the decreasing  of the membrane  fluidity and the growing of the  membrane  
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1/5 s 
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D P P C  : C h o i  =  2  :1  
0 .00 1 .00  2 . 0 0  
h  (nm"1)  
3 .00 
Fig.  16a and  b:  SAXS  results.  While the  orderliness  of  the membrane  is decreased  at the DPPC  liposomes  
(a), the DPPC / Choi liposomes has  permanent  structure during the temperature range (35-42 °C) of the  Lp-
La-  phase  transition  (b).  The  lamellar  repeat  distances  (dL)  slightly  decreased  (from 3.52  nm  to 3.45 nm)  at  
this  latter  system  which  phenomena  probably due  to the  change  of the  PL-hydrocarbon  chain  conformation  
during the phase  transition109.  
integrity  experienced  from  the  
Figures  14a to  14c. These effects 
are  summarized  on  the  Fig.  15.  
which  represents  the  adsorption  
of  DEX  on  different  liposomes  
and  was  prepared  on  the  basis  of  
the  quantitative  analysis  of  DEX  
with the use of  3HDEX. 
C,  The  role  of  surface  charge  
density 
The  deviance  of  the  surface  
charge  density  of  liposomes  
shown  in  Figure  13.  may  also  
influence  the  characteristics  of  
the  polymer-adsorption.  The  
negative  surface  charge  provided  
by  the  weakly  acidic  functional  
groups  may  polarize  the  
electron-structure  of  the  
polymers  to  be  adsorbed.  This  
effect  can  only  succeed  at  the  
PVP  more  significantly  among  
the  polymers  examined.  The  
nitrogen  in  the  2-pyrrolidone  is  
very  weakly  basic  and  we  
suppose  that  it  gets protonated  in  
aqueous  solution.  Through  this  it  
becomes  slightly  positively  F i g  1 7 a_ c :  Detection  of the polymer-adsorpion  with  DLS.  The  
charged  which  favours  the  initial  vesicle size diameters are in the Table 4.,  n=3 
attachment  of  PVP  to  negatively  charged  surfaces.  This  theory  might  be  the  reason  of  the  
phenomena  that  PVP bounds better  to  the  negatively  charged  SLPL / Choi / DCP  and  DPPC  
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/  Choi  /  DCP  liposomes  at  the  beginning  stage  of  adsorption  than  PVA  and  DEX  which  
interact  stronger other  cases.  
D,  The role of the  structural properties  of the  polymers  
At  the  explanation  of the  change  of adsorption  ability  observed  at  different polymers  it  
may  be  remarkable  the  quality  and  frequency  of  the  functional  groups  on  the  polymers  
suitable  to  form H-bridges,  and  the  average  molar  weight  of the  polymers.  We  can  see  on  the  
figures  14a-c  that  PVA  and  DEX  adsorb  in  higher  ratio  on  all  the  three  liposome  types  than  
PVP  does.  The  reason  of  this  deviance  should  probably  be  looked  for  in  the  better  H-bond  
forming  ability  of the  hydroxyl  groups  on  the  PVA  and  DEX  compared  to  the  oxo  groups  on  
the  PVP  molecules.  We  did  not  find  any  significant  difference  between  the  quantitative  
adsorption  properties  of  PVA  and  DEX  at  the  SLPL  /  Choi  /  DCP  liposomes  where  the  
polymer  segments  have  possibility  to  penetrate  into  the  membrane.  On  the  contrary  at  the  
other  two  DPPC-liposomes  with  more  rigid  membrane  where  polymers  can  only  bound  onto  
the  surface  we  experienced  measurable  difference  between  the  adsorption  of  PVA  (35-75  
mg/g)  and  DEX  (30-55  mg/g).  According  to  our  supposition  this  deviance  is due  to  the  more  
massive  adsorption  layer  of  the  DEX  resulted  by  the  smaller  molecular  weight,  the  ramified  
structure110  and  the  three  H-bond  forming  hydroxyl  groups  per  monomer  unit.  Whereas  this  
compact  layer  does  not  allows  
the  adsorption  of  further  DEX  
molecules  on  the  liposome  
surface,  in  the  case  of  PVA  
which  has  higher  molecular  
weight  and  only  one  hydroxyl  
group  per  monomer  unit,  the  
structure  of  the  adsorption  layer  
is  looser  and  gives  chance  for  
further PVA  molecules to  bind  as  
the  PVA  /  liposome  mass  ratio  
increases (Figures  14b and  c).  
time  (hours)  
Fig.  18.:  Titration  microcalorimetric  enthalpogram  of  
PVA/liposome  0.04-0.4  (w/w)  systems  from  which  the  AHIot  
values were calculated  by integration  of the areas under  peaks.  
3.4.  Examination  of polymer adsorption  with  DLS  technique  
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DLS  measurements  confirmed  the  results  described  before.  The  actual  vesicle  sizes  were  
compared  to  the  original  sizes  (Table  4.)  and  the  growth  of  liposomes  were  given  this  way.  
On  the  basis  of  the  Figure  17a-c  we  can  conclude  that  PVA  formed  the  thickest  adsorption  
layers  on  the  surface  of  all  the  three  liposome  types  with  the  maximum  liposome  growing  
values of  11.8 -  23.5  nm.  
3.5.  Heat  evaluation  of the  liposome-polymer  interaction  determined  by  titration  
microcalorimetry 
The  heat  production  /  absorption  during  titration  of  liposomes  with  PVA  is  illustrated  in  
Figure  18.  The  first  peak  reflects  an  exothermic  process  and  the  others  endothermic  effects.  
The  enthalpy  values  required  to  obtain  the  adsorption  enthalpy  are  listed  in  Table  5.  This  
enthalpy  is obtained  from  the  relation:  
AHads  — AHtot  -  (AHdil(PVA)  +  AHdil(liposomes))  ( 9 )  
where  A H a d S  is the adsorption  enthalpy,  
A H , o t  the total  enthalpy and 
AHd.i are the dilution enthalpies of the components  (PVA and  liposomes).  
The adsorption  enthalpy  is plotted  aganist  the equilibrium concentration  of PVA  (Fig.  
PVA /  liposome  
(w/w) 
AHtot 
(mJ) 
AHdii (mJ) of  
liposomes  (with  
buffer) 
AHdi, (mJ) of  PVA  
(added to  buffer)  
SAHdii  (mJ)  of  
PVA  and 
liposomes 
AHads (mJ) 
0.04 2.16 4.88 0.56 5.44 -3.28 
0.08. -0.78 3.43 -1.10 2.33 -3.11 
0.12 -2.99 1.23 -2.77 -1.54 -1.45 
0.16 -4.69 -1.94 -3.69 -5.63 0.95 
0.20 -6.16 -4.43 -4.66 -9.09 2.93 
0.24 -7.32 -5.90 -5.00 -10.90 3.58 
0.28 -8.46 -7.70 -4.87 -12.57 4.11 
0.32 -9.46 -9.45 -4.34 -13.79 4.33 
0.36 -7.99 -9.73 -2.76 -12.49 4.50 
0.40 -3.81 -4.70 -3.44 -8.14 4.33 
Table  5.:  Summary  of  TAM  results.  AHads  shows  exothermic  interaction  up  to approximately  C e P V A  =  0.04  
g/100cm3.  The standard  deviation  of  AHads was ±2.1-6.5 %, n=3.  
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19a).  The  interaction  is  
exothermic  up  to  a  PVA  
conentration  of  0.04g  /  100  cm3  
but  is  endothermic  at  higher  
concentration.  An  analogous  
representation  may  be  seen  in  
Fig.  19b,  where  the  adsorption  
enthalpy  is  related  to  1  g  
liposome  (AHads')  as  a  function  
of  the  amount  of PVA  adsorbed.  
This  relation  shows  that  in  the  
initial  stage  of  the  isotherm,  up  
to  an  adsorbed  amount  of  40  
mg/g,  exothermic  effects  are  
recorded.  The  differential  
adsorption  enthalpy  in  Fig.  19c  
shows  the  adsorption  enthalpy  
related  to  the  unit mass of PVA. 
These  data  clearly  
demonstrate  a  strong  exothermic  
interaction  between  the  liposome  
membranes  and  the  segments  of  
the  PVA  molecules  in  the  initial  
state  of  the  adsorption.  The  
interaction  may  primarily  
involve  hydrogen  bonding.  At  
higher  PVA  concentrations  
endothermic  interactions  occur  
which  indicates  that  the  polymer  
is  incorporated  between  the  alkyl  
chains  of  the  bilayer.  This  
500 
b  400  
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Fig.  19a:  AHads  shows  exothermic  interaction  up  to  ce  =  0.04  g  /  
100  cmf  The  ce  values  were  calculated  from  the  adsorption  
isotherm  (Fig.  14a,  Prot  aggregated  system).  19b:  AHads  per  gram  
of  liposome  as  a  function  of  the  amount  of  PVA  adsorbed  per  
gram  of  liposome  (nsPVA)-  19c:  Derived  form  of  Fig.  18b.  
Calculation  of the amount  of energy  liberated  by the adsorption  of  
1 g  PVA.  
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process  decreases  in the  structural  order  of  the  bilayers,  the  disorientation  of  the  alkyl  chains  
being  controlled  by  entropy.  It  must  also  be  considered  that  there  are  cholesterol  and  dicetyl  
phosphate  molecules  between  the  lecithin  phospholipids  and  the  hydroxyl  groups  of  
cholesterol  might favour the penetration of PVA  chains  into the  lipid  layer.  
3 
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3.6.  XRD  results  
In  the  PVA-liposome  systems  a  
lamellar  repeat  distance  (d[J  of  
4.71  nm was  found. After  storage  
in saturated  water  vapour  a  small  
degree  of  swelling  was  observed  
with  dL=  4.85  nm.  The  layer  
thickness  was  related  to  the  
structure  of  the  hydrated  lipid  
membrane  (Fig.  20.).  At  a  ratio  
of  0.305  PVA  /  liposome  dL  in  
the  dry  condition  was  3.94  nm.  
This  reveals  that  the  
adsorbed  PVA  compresses  the  
bilayer  by  connecting  molecules  
in  the  membrane.  When  this  
sample  was  exposed  to  water  
vapour,  two  well-characterized  
peaks appeared  with  dL= 6.13  nm 
and  dL=  3.57  nm,  which  are  probably  the  (001)  and  (002)  reflections  of  a  highly  expanded  
bilayer  with  a  spacing  of  about  7  nm.  The  nonintegrality  (dooi  is not  equal  to  doo2) indicates  a  
certain  interstratification  of  somewhat  differently  expanded  interlayer  spaces,  i.e.  the  
distances  from  interlayer  to  interlayer  of  the  expanded  phase  is  not  exactly  the  same.  The  
XRD  records  of  PVP-liposomes  reveal  essentially  the  same  effects (Fig.  21.).  In  dry  condition  
PVP  compresses  the  bilayer,  while  saturated  water  vapour  expands  the  membrane  to  dL= 4.43 
4.85 nm exposed to water  vapour  
4.71  nm dry 
PVA/liposome=0  (w/w)  
1 
=F 
5  7  
2 0  (degrees)  
Fig. 20.:  XRD diffractograms of  PVA-liposomes  
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nm.  This  expansion  is  maintained  after  further  addition  of  PVP  but  another  peak  appears  at  
7.06 nm which  is characteristic  of completely expanded  bilayers.  
A  comparison  of  the  XRD  results  for  the  the  two  neutral  polymers  with  liposomes  
suggests  that,  as  already  proved  
in  connection  with  adsorption  
isotherms,  PVP  binds  more  
weakly  on  the  surface  of  the  
bilayer  membrane  than  PVA:  at  
PVP/liposome  (w/w)  ratios  of  
0.025  and  0.61  the  expanded  
structure  show  dL=  4.43  nm  and  
4.56  nm.  The  amount  of  the  
highly  expanded  phase  with  dL  =  
7.06  nm  seems  to  be  distinctly  
smaller than for PVA. 
3.7.  Results  of  densimetry  
The  high  precision  densimertic  
measurements  were  done  on  the  
SLPL  /  Choi  /  DCP  systems.  The  
molar  excess  volume  (Vme)  
values  which  were  calculated  
with  the  Eq.  3.  are  plotted  in  the  
function of  polymer  /  liposome  mass  ratio  in the  Figure  22.  At  all the  polymers  decreasing  of  
the  Vme  was  observed  which  refers  to  the  compression  of  the  liposome  membrane  structure  
caused  by  polymer  adsorption.  The  rate  of  compression  is  the  most  expressed  in  the  case  of  
DEX:  5.71  cm3  /  mol  at  DEX  /  liposome  =  0.5  (w/w).  The  membrane-compressing  effect  of  
the polymers  is  smaller  rated  in the  PVA-liposome  systems  and  the  least  expressed  at  the  PVP  
where  the  deviance  compared  to  the  PVA  and  DEX  is  already  measurable  at  PVP  /  liposome  
=  0.04-012  (w/w).  Densimetric  results  support  the  theory  described  in 3/D  where  we  searched  
for explanation  on the different adsorption character-istics of polymers  examined.  
,7.06  nm 
3 
cs 
VI c 
4) 
exposed  to water  vapour  
PVP/liposome=0.61  (w/w)  
4.43  nm exposed to  water  vapour  
3.69  nm dry 
PVP/liposome=0.025  (w/w)  
2000 
cps 4.85  nm exposed  to water  vapour  
4.71  nm dry 
3  5  
2 0  (degrees)  
PVP/liposome=0  (w/w)  
Fig. 21.:  XRD difiractograms  PVP-liposomes  
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3.8.  Description  of  the  acridine  
orange entrapment  and  release  
3.8.1.  Optimisation  of the  remote  
loading 
The  results  obtained  from  the  
experiments  made  on  the  remote  
loading  process  with  three  
buffers  having  different  quality  
can  be  seen  in  the  Table  6.  It  is  
obvious  that  the  best  
polymer /  liposome  (w/w)  
o 
E m 
E u .—. 
v £ > 
0 
-1 
- 2 
-3 
-4 
-5 
- 6 
Fig. 22.  :  Molar  excess volumes calculated  from  the results  of  
high  precision  densimetry reveal the compression  of the 
membranes  of SLPL / Choi / DCP  liposomes.  
performance  was  given  by  the  systems  buffered with  Tris-HCl.  Among  them the  sample  AO  /  
PL  =  0.1  (molar  ratio)  was  found to  be the most  suitable  for the test  dye release  examinations.  
The  biggest  rate  of  entrapment  efficiency  (47.8  %)  with  the  smallest  increasement  of  the  
liposome  diameter  (195.2  nm)  was  observed  at  this  sample.  The  phenomena  of  vesicle  
enlargement  is  probably  explained  with  the  neutralizing  effect  of  AO  cations  on  the  
negatively  charged  phospholipids  packed  in  the  liposomal  membrane.  The  negative  surface  
charge  of  vesicles  which  maintains  the  stability  of  the  real  colloid  system  is  neutralized  after  
the addition of a certain amount  of AO.  This interaction  is followed by  aggregation.  
It  might  be  connection  between  the  quality  of  the  buffers  used  and  the  entrapment  
efficiency too.  Anions  in  the  buffer  systems  may  form  ionic  pairs  with  AO  cations  inhibiting  
the  formation  and  the  transport  of  the  AO  base  into  the  liposomes.  Hepes  molecules  with  
acidic  character  may  form  salt  with  AO  cations  in  the  extraliposomal  area  while  Tris  having  
basic  property  does  not  keeps  them  back  from  participating  in  the  membrane  transport  
mechanism.  Between  these  two  extremities  can  be  discussed  the  phosphate  buffered system  in  
which  the  hydrogen-  and  dihydrogenphosphate  anions  inhibit  the  AO  transport  into  liposomes  
in  lesser  extent  than  it  was  experienced  at  Hepes  anions  due  to  the  absence  of  non-polar  
interactions  and the  smaller  molecular  size.  
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AO/PL 
(mol/mol) 
Tris-HCl  buffer  phosphate  buffer  Hepes-NaOH  buffer  
Eopt  % ±  sd  d (nm)  ±  sd  Eopt  % ±  sd  d  (nm)  1  sd  Eopt  % 1  sd  d (nm)  1  sd  
0 0 150.8±15.0 0 153.1115.6 0 153.9115.9 
0.02 36.61 ±3.11 160.2±17.7 25.51+3.12 162.7116.2 13.0212.13 162.4117.1 
0.05 50.00±4.22 164.6±18.9 38.72±4.21 178.4125.5 39.2113.11 174.9124.6 
0.10 47.86+4.61 195.2+27.1 42.93±3.68 314.3130.3 33.3113.75 241.1132.8 
0.15 51.10±4.82 296.8±25.8 46.02±5.01 594.1140.8 30.5314.73 326.0130.9 
0.20 50.80±3.73 364.2±36.3 48.35±4.12 1588.1151.6 33.6214.36 658.8145.6 
0.25 46.54±3.92 643.4+42.9 43.12+3.56 2220.0152.5 27.9115.12 1304.9148.6 
0.30 45.45±4.31 1011.9±63.0 42.7114.26 2256.0196.6 26.9214.03 1905.1190.0 
Table  6.:  The  optimal  entrapment  efficiency  (Eopl  %)  and  average  vesicle  diameter  (d)  results  of  the  remote  
loading  process  of AO  into  liposomes.  The  data  used  for AO release experiments  are  shown  by italicised  fonts,  
n=3. 
3.8.2. Results  of the membrane  diffusion measurements 
These  experiments  were  made  on  the  SLPL  /  Choi  /  DCP  and  DPPC  /  Choi  liposomes  only  
because  the  average  vesicle  size  1642  nm)  of  the  DPPC  /  Choi  /  DCP  systems  would  not  
have  rendered  the  entrapment  of  AO  followed  by  separation  with  gel  permeation  possible.  
Results  of  the  operations  of  AO  entrapment  made  by  the  conditions  described  in  the  
experimental  section  and  the  gel  permeation  combined  with  centrifugation  are  summarized  in  
the Table  7. E  %  values  were  calculated  by  the  Eq.  4.  and  the  my  mass of AO  in  the  gel  
Type  of  liposomes  [PL]X 
(mM) 
[PL  ]y  
(mM  ± s d )  
E  %  
(%  1  sd)  
v 2 / W 
N0 
(mol) 
DLS2 
(nm  1  sd)  
S L P L / C h o i / D C P  =  
25  : 3  : 2 
26.66 
17.89 
± 2 . 0 1 
54.90 
± 6 . 4 0 
0.954 2.12  • 10"6 
211 
1  12  
DPPC/Choi  =  
2  : 1 
40 
24.75 
1 1 . 9 3 
72.05 
± 7 . 9 3 
0.943 3.36  • 10"6  
304 
± 2 1 
Table  7.:  Results  related  to  the  loading  of  AO  into  liposomes  and  the  removal  of  unentrapped  AO  by  gel  
prmeation.  The  DLS2  values  mean  the  increased  average  diameters  of  liposomes  after the  remote  loading  step.  
Standard  deviations were calculated  on the  basis  of three parallel  measurements  (n=3).  
permeated  liposomes  with  V2  
volume  by  the  Eq.  5.  During  the  
processes  of  AO  entrapment  the  
growth  of  the  neutral  DPPC  /  
Choi  liposomes  was  more  
expressed  (DLS2  =  304  ±  21  nm)  
than  the  SLPL  /  Choi  /  DCP  
liposomes  which  have  negative  
surface  charge  providing  
increased  kinetic  stability  for  
these  dispersions.  
The  final  results  of  the  
AO  release  exams  are  calculated  
by  Eq.8.  and  depicted  in  the  
Figures  23a  and  b.  The  polymer  
-free  SLPL  /  Choi  /  DCP  
dispersions  released  7.51  %  of  
the  originally  entrapped  test  dye.  
This  release-rate  is  similar  by  the  
order  of  magnitude  to  the  
liposomes  containing  SL-phospholipids  with  the  purity  of  99  % as major component" ' ' , J / .  At  
the  samples  containing  PVA  and  DEX  it  was  obviously  revealed  the  inhibition  of  the  AO  
diffusion which  is  due  to  the  membrane  structure  compression  shown  at  densimetry  and  the  
polymer  layer  formed  on  the  surface of  the  vesicles.  Whereas  at  the DEX  /  liposome  systems  
of  the  Figure  23a  mostly  the  membrane  compression  of DEX,  at  the  systems  containing  PVA  
rather  the  thickening  of the  polymer  layer  has  influence on the  efflux of AO  (Figure  23b).  On  
the  basis  of  the  measurements  the  amount  of  AO  released  during  24  hours  decreased  more  
determined  to  5.2  %  at  the  DEX  /  liposome  =  0.1  (w/w)  systems  than  at  the  systems  
containing PVA  in the  same mass ratio.  
In  the  case  of  DPPC  /  Choi  liposomes  AO  release  was  not  experienced  either  at  the  
polymer  free  or  the  polymer  contained  samples.  The  explanation  of  this  phenomena  can  
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Fig. 23a  and  b: Efflux of acridine orange  from the  SLPL / Choi  /  
DCP liposomal  systems containing  dextrane (a) and  PVA  (b)  
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obviously  be  traced  back  to  the  3  A  and  B  points.  Thus  the  rigid  membrane  of the  liposomes  
containing  cholesterol  in  33.3  %  (mol/mol)  is  in  the  Pp-  (rippled)  transitional  phase  at  37  °C  
which  is  still  very  orderly  (Figure  4.).  Through  these  facts and the  pH  gradient  exists  between  
the  inner  and  outer  sides  of  liposomes  AO  molecules  are  unable  to  leak  out  from  liposomes  
having  such lipid  composition.  
4.  Summary  
Interactions  between  liposomal  systems  with  three  different  lipid  compositions  and  PVA,  
PVP and dextrane macromolecules  were  examined.  
1.  Considerable  deviations  were  found  in the  behaviour  of the  systems  having different 
lipid  compositions  at  the  preparation.  In  addition  to  the  pH  of  the  dispersing  media  important  
role  have  the  grade  of  phospholipid  fatty  acid  saturation,  the  surface  charge,  and  the  lipid  
concentration.  In  general  I  can  say  that  physiologic  pH  (7.4)  provides  the  best  conditions  to  
prepare  any  kind  of liposome  easily.  SLPL  /  Choi / DCP  liposomes, pH  =  7.4:  d  =  148 ±  10  in  
phosphate  buffer (PB)  and  d =  150 ±  14 nm in phosphate  buffered saline  (PBS), pH  =  5.0:  d  =  
164  ±  13 nm. DPPC  /  Choi / DCP  liposomes, pH  = 7.4:  d =  110.4  ±  5.3  (PB)  and  d =  111.7  ±  
5.4  (PBS),  pH  =  5.0:  1642  ±  132  nm.  DPPC  /  Choi  liposomes,  pH  =  7.4:  d  =  114  ±  6.2  nm  
(PB) and  116 ± 7.3 nm (PBS), pH = 5.0:  d =  151 ±8.1  nm.  
2.  The  composition  of  liposomes  influences  not  only  the  preparation  process  but  also  
the  polymer  adsorption  on  the  liposomal  membrane.  At  the  experimental  conditions  employed  
the  fluid,  liquid  crystal  phased  (La-)  SLPL  /  Choi  /  DCP  liposomes  bind  all the  three  polymers  
in higher  ratio  than the other two  systems which contain DPPC  as major component  and  are  in  
the  orderly  gel  (Lp-) phase.  Polymers  are  not  only  able  to  adsorb  onto  the  surface  of the  (La>)  
phased  membranes  but  also penetrate  into  their  structure.  
3.  The  surface  charge  density  of  liposomes  and  physical  chemical  properties  of  the  
polymers  have  also  effect  on  the  adsorption  characteristics.  In  general  PVA  and  dextrane  
which  are  rich  in  hydroxyl  groups  adsorb  better  than  PVP  at  which  adsorption  properties  has  
determining  role the negative  surface charge of the  lipid  membranes.  
4.  Results  experienced  at  the  quantitative  polymer  adsorption  measurements  were  also  
confirmed  by  DLS  examinations  where  I  found  the  biggest  adsorption  layer  thicknesses  -
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which  as  value  (ts)  is  half  of  the  growth  of  liposomes-  at  the  SLPL  /  Choi  /  DCP  systems  
containing PVA (tsmax «11.8 nm) and dextrane (tsmax «10.8  nm).  
5.  Enthalpy  values  of  the  titration  microcalorimetric  exams  are  exothermic  at  the  
beginning  stage  of  the  adsorption  which  fact  reveals  that  these  interactions  are  hydrogen  
bonding.  If  we  increased  the  PVA  concentration,  the  heat  effects grew  endothermic  which  
probably the consequence of the polymer-penetration into the lipid membrane. 
6.  XRD  diffractograms show that  PVA  allows  smaller  expansion  for the  lipid  bilayer  
than PVP  if I  exposed the  lipid films prepared  from  liposome  dispersions  containing different 
amount  of  polymers  to  water  vapour.  The  diminishment  of  the  molar  excess  volume  values  
(Vm®) obtained  by  further  calculation  from the  results  of  high  precision  densimetry  revealed  
the  compression of the  lipid membrane  structure.  This phenomena was the most  expressed  at  
the systems containing dextrane. 
7.  At  the  preliminary  experiments  of  the  acridine  orange  (AO)  release  tests  I  have  
concluded  that  the  active-  or  remote  loading  of AO  is  optimal  at  the  AO /  PL  rate of  0.1  in  
Tris buffered saline considered to the entrapment efficiency and the rate of aggregation. 
8. The polymer  barrier  and the membrane compression  formed through the  adsorption  
process decreased the AO release of SLPL / Choi / DCP liposomes. There was no AO release 
experienced  at the DPPC /  Choi liposomes which is an obvious evidence that the efflux of the 
test  dye  is  influenced  by  the  composition  of  the  liposome  membrane  primarily.  
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